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ABSTRACT 
Pawinee Doung-ngern: Epidemiology of Q fever among dairy cattle and dairy farmers, 
Chiang Mai, Thailand 2015 
(Under the direction of Steven Meshnick) 
Q fever is a zoonosis, caused by the gram negative bacteria Coxiella burnetii. Knowledge of the 
epidemiology of Q fever in Thailand is limited. This study was conducted to determine the burden and the 
risk factors of C.burnetii infection in dairy cattle farms and farmers in Chiang Mai, Thailand. A prospective 
cohort study was conducted in five dairy cooperatives where evidence of C.burnetii was reported. The 
project included three components 1) a cohort study among farmers, 2) bulk tank milk (BTM) screening, 
and 3) farm investigation and specimen collection from cows and their environments in milk positive 
farms. Samples and data collection were obtained at baseline, 6, and 12 month intervals. Human sera 
were tested using Indirect Immunofluorescense Assay; cow sera and BTM were tested using Enzyme 
Linked Immunosorbent Assay; and vaginal swab and environmental samples were tested using 
Polymerase Chain Reaction. Baseline data were analyzed using logistic regression and Generalized 
Estimating Equation models to estimate the odds ratio (OR) and 95% confidence interval (CI). Among 
306 randomly selected farms, 282 farms (92.2%) and 532 from 637 randomly selected farmers (83.5%) 
participated. The prevalence of C.burnetii antibodies in BTM was 40.8% (115/282) and the C.burnetii 
seroprevalence among farmers was 16.9% (90/532). Investigation in BTM positive farms showed 
C.burnetii seroprevalence was 28.4% (224/790) at the individual cow level and 91.9% (91/99) at the farm 
level. Multivariate analysis showed that having more than 80% of cows ≥ 2 years of age (OR 2.34, 95%CI 
1.09 - 5.06) and having an infected farms within 1 km (OR 2.88, 95%CI 1.17 – 7.06) were positively 
associated with the odds of C.burnetii antibodies in BTM. Cleaning the birthing area (OR 0.27, 95%CI 
0.08 - 0.86) and quarantining newly purchased animals (OR 0.54, 95%CI 0.30 - 0.97) provided protection. 
Working in a milk positive farm and exposure to birth products during calving were associated with 
seropositivity among farmers. This study provides useful information for Q fever prevention and control. 
Health education regarding Q fever prevention should be provided to farmers and public health and 
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animal health officers in high risk areas in Thailand.  
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To livestock farmers in Thailand. This work could not be accomplished without their support.  
I hope this work will contribute to an improvement in the awareness of occupational risk to 
prevent the occurrence of Q fever among this high risk population. 
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CHAPTER 1 
SPECIFIC AIMS 
Q fever is a zoonosis, caused by the gram negative bacteria Coxiella burnetii. It is highly contagious 
and classified as a category B bioterrorism agent (1). It is capable of causing a large outbreak, resulting in 
high morbidity in humans, loss of several animal lives, and can have potential impact on an economy as 
reported in an outbreak in the Netherlands (2, 3). The main route of transmission is by inhalation of 
aerosols contaminated with infected animal secretions. Q fever can infect a variety of hosts such as 
humans, ruminants, dogs, cats, and ticks. Human exposure to host animals creates a high risk of 
infection (4). Most of the infections are asymptomatic, but Q fever can cause abortions and weak 
offspring in animals, and a flu-like symptom as well as pneumonia and hepatitis in humans (5, 6). 
Moreover, it can cause chronic sequelae in humans including endocarditis in 1 – 5% and chronic fatigue 
syndrome in 10 – 20% of infections (7-10). Q fever diagnosis relies on laboratory analyses, particularly 
serological tests. In Thailand, information about Q fever is limited. It is not a notifiable disease, laboratory 
capacities are limited, and no epidemiological study has been conducted to understand the risk factors of 
the disease (11-14). Studies conducted in 2012 suggested that Q fever might be endemic among 
ruminants in Thailand and the burden of Q fever in humans might be higher than expected. The most 
recent studies found evidence of C. burnetii DNA in ruminants in 9 provinces in Thailand (15), while the 
seroprevalence of Q fever was 16% among dairy farmers in Chiang Mai (16). A genotyping study of 
animal placentas in Thailand showed that dairy cows had positive ST18 (Pattarin et al., unpublished), the 
strain associated with acute disease in humans (17). Thus, dairy cows could be a significant source of Q 
fever in humans, and dairy farmers in Thailand might have an increased risk of infection in Thailand. To 
be better prepared and to prevent outbreaks of Q fever, the epidemiological study of Q fever is essential. 
The specific aims of this study are to:  
1. Describe the burden and factors associated with C. burnetii infection in dairy cow farms using bulk 
tank milk (BTM) as a proxy for Q fever infection at the herd level.   
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1.1. Describe the prevalence of antibodies to C. burnetii infection in dairy farms 
1.2. Identify factors associated with Q fever in dairy cow farms (Q fever positive milk) 
Hypothesis: Not cleaning the birthing area after birth increases the chance of Q fever positive in the farm 
Rationale: Livestock, including cattle, are the most frequent source of Q fever infection in humans (6, 8). 
A previous study in Chiang Mai, Thailand, showed that dairy cows could be a significant source of Q fever 
(Pranee, Padungtod poster). The study reported on here was conducted in five dairy cooperatives in 
Chiang Mai Province where a previous study showed evidence of Q fever during June 2015 – August 
2016 (16). Farms were randomly selected from the list of the dairy cooperatives. BTM was tested at 
baseline, with two additional follow ups at 6 and 12 month intervals. Farm representatives were 
interviewed about farm characteristics and farm management. If the screening was positive, a farm 
investigation including sample collection from 8 cows per farm, other animals, and the farm environment 
was performed. This dissertation is part of the main project, but only baseline information was used for 
data analysis. Prevalence and factors associated with the antibody to C. burnetii in BTM were evaluated 
using logistic regression.  
 
2. Describe the burden and factors associated with Q fever among dairy farmers  
2.1. Describe the seroprevalence of Q fever among dairy farmers  
2.2. Identify factors associated with C.burnetii infection or Q fever among the dairy farmers 
Hypothesis: Being close contact with dairy cows, particularly during calving, increases the risk of 
acquiring Q fever. 
Rationale: Q fever can cause serious outbreaks and pose chronic life threatening sequelae, such as 
endocarditis in humans (18). Understanding the epidemiology of Q fever among high risk populations is 
crucial for targeting and implementing intervention. A prospective cohort study among dairy farmers was 
conducted. Farmers were randomly selected from participating farms, as described in aim 1. Face to face 
interviews by trained interviewers using a tested questionnaire were performed to collect all necessary 
information. Interviews and blood collections were conducted at the same time as the study of BTM 
(aim1). Sera were tested using Indirect Immunofluorescence Assay (IFA). Information about farmers, 
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farms, and the environment were incorporated and analyzed using the Generalized Estimating Equation 
(GEE) to evaluate factors associated with seroprevalence of Q fever infection among dairy farmers.  
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CHAPTER 2 
INTRODUCTION AND LITERATURE REVIEW 
Q fever (Query fever) 
Q fever was first described in 1937 in Australia after an outbreak of acute febrile illness among 
abattoir workers. It was named Q (query) fever since the origin was unknown at that time. Q fever is a 
zoonotic disease, caused by gram negative intracellular bacteria called Coxiella burnetii. (8, 19). The 
bacteria are highly contagious and require a biosecurity level 3 laboratory. C. burnetii is classified as a 
category B bioterrorism agent (second highest priority) because it is resistant to severe environments, 
moderately easy to disseminate, can cause a high morbidity rate, and requires specific management and 
surveillance (1). The bacterium can form a spore-like structure, called a small-cell variant (SCV), which 
can resist extreme environments such as heat or aridity and chemical agents such as disinfectants. In 
addition, the bacteria also have large-cell variant (LCV) components which will multiply in the host 
immune response cells including monocytes and macrophage (4, 20).Previous studies have shown that 
C. burnetii can survive up to two weeks in contaminated aerosols, more than one month on meat in cold 
storage, and up to five months in contaminated soil (8, 21, 22). A study by Kersh et al. showed that  
C. burnetii can persist in the environment even one year after an outbreak (23) and viable C. burnetii 
were found in the environment in the areas with and without livestock such, as a bank, a city hall, a 
community center, etc. (24). C. burnetii has two antigenic variations when cultured in eggs or cell cultures. 
Phase I, a virulent form, is the natural phase found directly in infected humans or animals. Phase II, a 
non-virulent form, is obtained in the laboratory after repeated passages through cell culture (4, 8).  
Infection in animals mainly spreads via air-borne transmission. Infected animals shed the bacteria via 
their secretions such as birth products, milk, urine, and feces, regardless of clinical symptoms (6, 25). The 
shedding might persist for several months, especially in vaginal mucus, feces, and milk (26). Cows and 
goats shed the bacteria through milk more often than do sheep (27). Ticks are suspected as the source of 
infection among animals (20, 28). In addition, ticks are suspected to be a sustaining source of infection in 
5 
both animals and humans because they can shed a large number of bacteria via their feces which then 
can become contaminated dust when dry (20, 28, 29). Ingestion of placenta or milk from infected 
ruminants or infected rats is another possible source of infection, as reported in dogs and cats (20). 
Humans are infected mainly by inhaling aerosol particles or dust contaminated with infected animal 
products such as amniotic fluid, urine, or feces (4, 30). Studies have shown that wool, shoes, clothing, 
straw, and other materials contaminated with animal excreta are suspected vehicles for disease 
dissemination (22, 31, 32). Other less common routes of transmission include food-borne transmission, 
blood transfusion, bone marrow transplants, mother to child transmission, and sexual transmission (10, 
20, 22, 30, 33-37). Person-to-person transmission is very rare. One example of such transmission is the 
report of Q fever infection after attending an obstetrical procedure on a patient and fetus with Q fever (36, 
38). Investigations of previous outbreaks have shown that infection can occur under several other 
conditions, for example, wind-borne contamination from a slaughter house (39-41), likely infection from 
contaminated clothes among laundry workers at a Q fever laboratory (31), and ingestion of milk and 
cheese (42, 43). Most Q fever infections in humans are reported to be associated with ruminants contact; 
however, some studies report that close contact with domestic pets including cats and dogs can be 
associated with Q fever infection (44, 45). 
 
Clinical manifestations   
Infection in animals is usually asymptomatic. Nonetheless, Q fever can cause miscarriages, stillbirths, 
weak offspring, retention of the placenta, metritis, and infertility in mammals (6). These clinical symptoms 
are usually presented in sheep and goats. Q fever infection in cattle is mostly asymptomatic, but metritis 
is the more common clinical manifestation of the disease in cattle and can last for several months (46-48). 
C. burnetii infection caused a big outbreak of abortions and stillbirths among dairy goats in the 
Netherlands in 2007 (49) and was attributed to 0.5 – 3.8% of abortions in cattle in Germany (27). 
Regardless of clinical manifestation, infected animals can shed bacteria through their mucosal discharges 
and secretions. Infected cows and goats can shed the bacteria for a longer time in milk, e.g., infected 
cows can shed bacteria in milk for 13 months. Additionally, infected sheep can shed bacteria more 
through vaginal secretions (47). One study showed that 65% of infected cattle shed bacteria by one route; 
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milk is the most frequent route of shedding (33.6%) compared to vaginal mucus (10.9%) or feces (20.9%) 
(50). Combined shedding routes are also possible. For example, 15% of infected cattle shed bacteria 
through their feces and vaginal secretion, 10.0% shed via their milk and vaginal secretions, 3.6% shed in 
both their milk and feces, and 6.4% shed the bacteria in milk, vaginal mucus and feces (50). In addition, 
cows developed chronic infections more frequently than sheep. As a result, cows tend to shed the 
bacteria for a longer period than sheep (48). 
Similar to infection in animals, the majority of Q fever infections in humans are asymptomatic. The 
incubation period of Q fever in humans usually ranges from 2–3 weeks after exposure, with the longest 
reported incubation period of 2 months (8, 51). Incubation periods and clinical manifestations in humans 
are influenced by host factors such as the immune system status of the patients, bacteria strain 
specificity, dose of the bacteria, and the route of infection to which each individual has been exposed 
(30). One study of human subjects showed that subcutaneous and intramuscular injections need a 
smaller inoculum to cause the disease; for these individuals the incubation period was as fast as 1–2 
days among the subjects who received intramuscular injections (52). About 40% of humans infected with 
Q fever develop acute Q fever which usually presents with a fever, headache, myalgia, chills, and fatigue. 
Some patients develop severe symptoms such as pneumonia, hepatitis, meningitis, encephalitis, or 
myocarditis (8). The case fatality rate is approximately 1 – 2% (4). Approximately 2 – 5 % of acute Q fever 
infections require hospitalization (30, 53). However, in the outbreak in the Netherlands, the largest 
outbreak of Q fever reported to date, the percentage of hospitalizations could reach 20% (49). Infection in 
pregnant women can cause serious pregnancy complications (38, 54-56). Approximately 80% of 
untreated pregnancies with Q fever have obstetric complications including abortions, fetal deaths in utero, 
preterm deliveries, and intrauterine growth retardation (56). Furthermore, Q fever can cause chronic 
infections in humans regardless of acute stage clinical manifestations. Chronic infections can develop 
within a few months or several years after infection (10). Approximately 1–5 % of infections develop 
endocarditis, a chronic life-threatening condition (9, 57). In addition, approximately 10–20% of patients 
develop chronic fatigue syndrome which can last for years and reduce quality of life (2, 4). People with 
underlying valvular heart disease, immunocompromised patients, and pregnant women are at high risk of 
developing chronic infection (10, 30).  
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Q fever infection in children has been reported, but they are less likely to develop symptoms when 
compared to adults (53). Children with Q fever infections can present with fever, weakness, coughing, 
vomiting, diarrhea, abdominal pain, rashes, and pneumonia. Severe symptoms in children, including 
hepatitis, hemolytic uremic syndrome, myocarditis, pericarditis, osteomyelitis, meningoencephalitis, and 
rhabdomyolysis are rare, but possible (10, 53). Chronic Q fever in children has been reported in patients 
presenting with endocarditis and osteomyelitis. A review by Maltezou et al. in 2002 found 5 reported 
cases of children with Q fever endocarditis. The median age was 7 years (minimum and maximum age 
range 3.5–11 years) (53). In addition, a review by Nourse et al. in 2004 showed that 14 cases of Q fever 
osteomyelitis were reported worldwide and 6 of them were children with ages ranging from 2 – 9 years 
(58). 
 
Laboratory diagnosis 
Since clinical presentations of Q fever are nonspecific and exposure history with animals may or may 
not be helpful, diagnosis of Q fever in animals and humans is usually based on laboratory analysis. 
Serology is the most common diagnostic tool since it is less complicated when compared to culture and 
molecular biology techniques which have lower sensitivity and require a more sophisticated laboratory 
capacity (at least BSL3) (8, 10). Indirect Immunofluorescence Assay (IFA) is the current reference 
laboratory method for Q fever serological diagnosis (6, 8, 53).  IFA can detect both phase I, a virulent 
form found in patients with chronic infection, and phase II, a non-virulent form found in patients with acute 
infection (4, 8). Therefore, IFA is also used for monitoring the progression of the disease to chronic 
infection and the effectiveness of treatment in chronic Q fever patients (8, 10). However, IFA has certain 
disadvantages as the interpretation is more subjective and tiring, and is expensive. Enzyme-linked 
immunosorbent assay (ELISA) is another serological method more widely used especially for 
seroepidemiological studies because it is easier to perform and has high sensitivity (8). ELISA is a 
qualitative test, hence, changes in antibody titer cannot be measured. The compliment fixation test (CF 
test) is another common laboratory method used in the past. It has high specificity, but lower sensitivity 
and is more time consuming when compared to IFA or ELISA (8). In addition, CF tests fail to detect 
seroconversion in the early stages of infection. Previous studies have shown that the CF test can detect 
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seroconversion 14–21 days after onset whereas IFA can detect it in 10–15 days (59). Some studies 
determine the sensitivity and specificity of these serological tests for Q fever diagnosis. Nonetheless, the 
interpretation of sensitivity and specificity can be challenging because there is no good gold standard 
laboratory diagnosis for Q fever. As a result, reference test bias might be possible. Most studies used 
another serological test as the gold standard. For example, the study by Meekelenkamp et al. showed 
that the sensitivity of IFA was 100.0%, the specificity was 95.3%, the positive predictive value was 95.5%, 
and the negative predictive value was 100.0% using a combination of IFA and ELISA results as the gold 
standard (60). The sensitivity of a commercial ELISA ranges from 85.7–99% and the specificity ranges 
from 87.6 – 97.6% using IFA as a reference (60, 61).  
Polymerase Chain Reaction (PCR) is useful for C. burnetii DNA detection in a timely manner. 
However, PCR is only sensitive when the specimens are collected within the first two weeks of onset and 
before antibiotic administration (10). PCR is very sensitive for detecting bacteria shedding in animal 
secretion, milk, and tissue samples such as heart valves, placenta, and fetal tissue (4). However, the 
sensitivity of PCR tests on human sera are inconsistently reported. A 2003 study showed that the 
sensitivity of PCR was only 24% among patients who had symptoms clinically compatible with Q fever 
and had seroconversion (62). A more recent study conducted during a large outbreak of Q fever in the 
Netherlands in 2010 showed that the sensitivity of PCR was 98% in the acute serum (fever day 5 or 
earlier) of patients with serologically proven Q fever infection whose acute phase sera were also 
seronegative. Moreover, the positivity of PCR was lower when the antibodies were developed (63).   
The US National Notifiable Diseases Surveillance System (NNDSS) has defined laboratory diagnostic 
criteria for acute and chronic Q fever as confirmed or supportive conditions (64). Laboratory confirmed 
acute Q fever is defined as: 
- Having serological evidence of a fourfold increase in immunoglobulin G (IgG)-specific antibody 
titer to C. burnetii phase II antigen by indirect immunofluorescence assay (IFA) between acute 
and convalescent sera taken 3 – 6 weeks apart OR 
- Detection of C. burnetii DNA in a clinical specimen via amplification of a specific target by 
polymerase chain reaction (PCR) assay, OR 
- Demonstration of C. burnetii in a clinical specimen by immunohistochemical methods (IHC), OR 
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- Isolation of C. burnetii from a clinical specimen by culture. 
Laboratory supportive acute Q fever is defined as:   
- Having a single supportive IFA IgG titer of ≥1:128 to phase II antigen OR 
- Having serologic evidence of elevated phase II IgG or immunoglobulin M (IgM) antibody reactive 
with C. burnetii antigen by ELISA, dot-ELISA, or latex agglutination. 
For chronic Q fever, laboratory confirmed chronic Q fever is defined as any patient who has clinical 
symptoms compatible with culture-negative endocarditis, or suspected infection of a vascular 
aneurysm/prosthesis, or chronic hepatitis, osteomyelitis, osteoarthritis, or pneumonitis with one or more of 
the following laboratory results: 
- IgG titer ≥ 1:800 to C.burnetii phase I antigen by IFA  
- Detection of C. burnetii DNA in a clinical specimen by PCR 
- Demonstration of C. burnetii in a clinical specimen by IHC  
- Isolation of C. burnetii from a clinical specimen by culture 
In addition, laboratory supportive chronic Q fever is defined as IFA IgG titer to C. burnetii phase I 
antigen ≥ 1:128 and < 1:800.  
A Q fever diagnostic criterion using IFA in a single serum can vary by country depending on the 
baseline prevalence of the disease. A guideline in France suggested that a single IFA IgG titer to C. 
burnetii phase II antigen ≥1:200 is considered recent acute Q fever infection (8). IgM is not recommended 
for diagnosis of acute Q fever because IgM may persist at a low level for a long period of time and IgM 
alone might not be a good indicator for active infection (65).   
For animals, the CF test is more widely used for diagnosis of Q fever particularly in a routine 
diagnosis at the herd level for abortive diseases (6). Interpretation of the serology test in animals needs to 
be cautious. The animals might seroconvert after exposure to C. burnetii, but not shed the bacteria (4, 6, 
66). Moreover, infected animals can also shed the bacteria without having seroconversion (66). Thus, a 
serological test is useful to detect the prevalence of Q fever, but it is not a reliable method to determine 
whether specific animals are the potential sources of transmission of C. burnetii to humans or other 
animals. To detect shedding sources, the PCR test of animal body fluids such as milk, vaginal mucus, 
and feces is more reliable (10).  
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Epidemiology of Q fever 
Q fever is a worldwide zoonotic disease. It has been reported in at least 51 countries globally (67). 
Nonetheless, an understanding of the actual prevalence of Q fever in humans and animals is unknown 
because the diagnosis of Q fever is based on laboratory tests and laboratory capacities are not available 
in many parts of the world (68). In addition, a comparison between serological studies can be challenged 
because of the differences in serological methods and the cut-off points used in each study (66).   
In animals 
C. burnetii can infect a variety of hosts including domestic and wild animals, such as livestock, cats, 
dogs, rodents, birds, fish, reptiles, and ticks (20). However, cattle, sheep, goats, and domestic pets are 
the most likely sources of infection in humans (8, 25). The presence of Q fever in ruminants varies by 
country. For example, Q fever was more prevalent in goats in Iran (69), France,  and the United States, 
but was more prevalent in cows in Japan and Zimbabwe (27, 70, 71). Domestic pets such as dogs and 
cats can be infected with Q fever. The seroprevalence study in the United States found that dogs have a 
higher prevalence of Q fever than cats (53% vs 9%) (71), whereas a Japanese study found similar 
proportions of Q fever in cats and dogs (15% vs 10%) (70). The role of dogs in Q fever transmission to 
humans is not clear (45), but having close contact with a cat’s parturient was suspected to be associated 
with Q fever infection in humans in Nova Scotia, Canada (72) , and in Maine, United States (73). A 
seasonal pattern of Q fever has been observed in European studies where Q fever was more prevalent in 
the summer or during lambing and calving seasons (74-76).  Seroprevalence studies showed that 
increases in age, number of parity, specific breeds such as Danish Holstein, herd size, and farm practices 
including having loose housing in the stable, no quarantine of newly purchased animals on the farm, and 
a lack of hygienic precautions of the veterinarian while on the farm were positively associated with the 
seropositivity of Q fever among dairy cattle (74, 77). 
C. burnetii has been found in more than 40 species of ticks (8, 48, 78).  The role of ticks in Q fever 
transmission is not clear. Ticks were suspected to have a role in the transmission of C. burnetii between 
wild animals and from wild to domestic animals (71, 79). Nonetheless, previous studies in endemic areas 
of Q fever in Germany and Spain showed that the proportion of ticks testing positive by PCR was very 
small or zero (80, 81). Despite the suspicious role of ticks in Q fever transmission, infected ticks can 
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excrete the bacteria through their saliva and feces. The study showed that infected ticks excrete high 
amounts of bacteria in their feces, reaching 10
12
 organisms per gram (48). When they dry, the feces can 
contaminate dust particles and, therefore, possibly transmit the disease to other animals and humans.  
 
In humans 
A surveillance system for Q fever has not been widely put in place. Most of the available data about Q 
fever has come from seroprevalence studies. Thus, comparisons of prevalence among different areas 
can be difficult, since such prevalence may vary depending on the time of the study, the geographical 
location, population tested, laboratory methods, and cut-off points. Seroprevalence studies in the United 
States and Japan found that approximately 3% of the healthy adult population and 10–20% of persons in 
high risk occupations such as farmers and veterinarians had antibodies to C. burnetii (70, 82). A report 
from the Netherlands showed that the seroprevalence of C. burnetii was 2.4% among the general 
population, 12.2%-24.0% among blood donors, and 83.8% among high risk groups. In contrast, the 
seroprevalence of C. burnetii among blood donors was 22.0% in Germany and 38.0% in Bulgaria (27). Q 
fever outbreaks were reported in several countries (8, 70). However, the largest outbreak ever reported 
took place in the Netherlands from 2007 – 2010 where goats were the source of the outbreak and over 
3,500 human cases were identified. More than 20% of the patients were hospitalized and several goats 
were killed for outbreak control purpose (3). The estimated loss from this outbreak was 307 million Euro 
(2).  
Q fever can be considered an occupational hazard for people whose work involves close contact with 
animals; livestock farmers and veterinarians are at a high risk of infection (8, 10). A study of national 
disease surveillance in the United States showed that persons who had a history of livestock contact, 
including farmers, veterinarians, slaughterhouse workers, and tannery workers, had higher prevalences of 
antibodies to C. burnetii when compared to those who did not have a history of livestock contact (71). 
Nonetheless, close contact is not necessary to acquire Q fever infections; evidence of windborne 
transmission is indicated for several outbreaks of Q fever (40, 83-85). Studies have shown that the closer 
a residential area is to a farm with a history of abortions, the higher the proportion of Q fever infection (84, 
86). The study in the Netherlands describing the serious outbreak of Q fever showed that people living 
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within 5 kilometers of infected farms were at an increased risk of getting Q fever infection (86). In 2014, 
an unusual outbreak of Q fever was reported among six people who received intramuscular injections of 
fetal sheep cells in Germany. This live cell therapy was believed to improve these people’s general 
health, but no published articles to date have supported such a notion (87).   
Q fever can affect people of all ages, but the majority of reported cases are in people of working age, 
particularly those aged >40 (88, 89). A study in the United States found that the number of Q fever cases 
increases with age; the peak was in those in the 50–59 year-old group (89). This finding could be 
explained by an increase in exposure to bacteria with age. Q fever is rarely reported in children, but is 
possible. The youngest reported age was 8 months (53). The majority of reported Q fever cases are male 
(8). Previous studies have shown that males have a higher risk of developing symptomatic Q fever than 
females. This might be explained by the protective effects of estradiol in females as shown in animal 
studies (90) and sex-associated occupational exposure in males (91). 
Unlike Q fever in animals, a seasonal pattern of Q fever in humans is inconclusive. A review of the 
national disease surveillance in the United States showed evidence of a seasonal pattern with almost 
40% of cases occurring from April to June (89), similar to the findings in France (92) and England (93). 
However, no definite seasonal pattern has been observed in Australia (94).   
 
Prevention and control of Q fever 
Vaccines, strengthening of environmental cleaning and hygiene, and the use of personal protective 
equipment are recommended to prevent and control Q fever. 
Prevention 
Vaccines against Q fever are available for humans and animals. Nonetheless, vaccines are not 
widely available or used in many countries. The most common type of vaccine is the whole-cell 
inactivated vaccine because it causes fewer adverse reactions and fewer complications when compared 
to the live attenuated vaccine. Vaccine in animals, particularly ruminants, is mainly used in Australia and 
Europe (95). Studies have shown that a vaccine can provide protection for C. burnetii negative animals 
and can partly prevent the shedding of the bacteria in milk, animal fluids, and birth products (50, 95). A 
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study of cows also showed that vaccination before pregnancy reduced a significant amount of bacteria 
shedding compared to vaccination during pregnancy and a placebo (50).  
Vaccines are not widely used in humans because of serious side effects, the complexity of vaccine 
administration, and cost. Q-vax is the most recent vaccine used in humans. This vaccine can cause 
severe adverse effects such as severe local inflammatory or general systematic reaction in previously 
infected individuals. Therefore, vaccination is not recommended for those who have been previously 
infected. In addition, vaccine administration requires a prescreening for previous infection by either a skin 
or serology test (25). As a result, a vaccine is not feasible to use in a number of settings, especially in 
countries where laboratory capacities for Q fever diagnosis are limited. Vaccines are used in Australia 
among high risk populations such as abattoir workers and veterinarians (25, 96). Clinical trials and cohort 
studies on the efficacy of Q fever vaccine conducted in Australia showed that the vaccine efficacy in 
humans ranged from 83–100% (25, 96). However, the randomization and double-blind methods were not 
clearly explained in these clinical trial studies (96). 
The use of personal protective equipment (PPE) including gloves, boots, and masks whenever an 
individual is exposed to animal secretions is also recommended to prevent the disease. Post exposure 
prophylaxis is not recommended for the general population. No scientific study has been conducted to 
evaluate the efficacy of post-exposure prophylaxis. However, doxycycline 100 mg twice daily or 
tetracycline 500 mg orally every 6 hours for 5 – 7 days, started 8 – 12 days past exposure is 
recommended for post exposure prophylaxis for essential personnel or for those considered at high risk. 
Early administration of the antibiotic within 7 days after exposure is not useful and will lengthen the onset 
of the disease (10, 35, 97). 
Control  
Like other zoonotic diseases, Q fever control in animals is vital to manage outbreaks for both animals 
and humans. Bacterial decontamination is essential once Q fever infection is evident. To reduce bacterial 
contamination of the environment, good hygiene practices on the farm are advocated. 0.4 – 0.6% calcium 
cyanamide or lime is recommended for treatment of manure, aborted fetuses, infected fetal fluids, and 
membranes before incineration or field burial. This process must be done in the absence of wind to avoid 
spreading bacteria (20, 26, 48). United Kingdom Health Protection Agency guidelines recommend use of 
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2% formaldehyde, 1% Lysol, 5% hydrogen peroxide, 70% ethanol, or 5% chloroform for surface 
decontamination. In addition, spills of contaminated materials should be cleaned immediately using 
hypochlorite (5000 p.p.m. available chlorine), 5% peroxide, or phenol-based solutions (65). Determination 
of C. burnetii and its viability after decontamination is recommended, but might not be feasible. Milk from 
infected dairy animals should be discarded. Milk from uninfected animals on the same farm can be used if 
pasteurized at 72°C for 15 minutes or by a similar thermal treatment, unless it is highly suspected that 
dairy products are dangerous for human consumptions (48). Antibiotic treatment with tetracycline 
injections the last month of gestation is used to reduce the occurrence of abortion and bacteria shedding 
into the environment during parturition. However, no study has confirmed its effectiveness (26). Although 
the roles of ticks in Q fever transmission are not clearly identified, tick control is suggested to reduce the 
sustainability of the bacteria in the environment (20, 98).  
Human-to-human transmission is infrequent and secondary transmission among humans is very rare. 
Nevertheless, standard hospital infection control practices such as wearing masks, gloves and gowns are 
recommended when taking care of C. burnetii infected patients. Staff members who participate in the 
obstetric and gynecological procedures of pregnant women with Q fever or who carry the specimens 
suspected of C. burnetii contamination must wear N-95 masks, surgical gloves, and protective gowns. 
Decontamination of materials spilled with Q fever patient’s secretions should use 0.05% hypochlorite, 5% 
peroxide, or phenol-based-solutions performed immediately. Contaminated equipment or instruments can 
be decontaminated by autoclaving or boiling for 10 minutes (35). 
 
Treatment of Q fever 
Treatment of Q fever is controversial in animals since the majority of infections are asymptomatic. To 
date, no effective treatment to eradicate the shedding of bacteria from infected animals has been 
discovered (97). Parental treatment of individual animals with oxytetracycline at 20 mg/kg given 20 days 
apart in late gestation to prevent adverse pregnancy outcomes might be useful when abortions are active 
in the herd (97). Nonetheless, information on the effectiveness of antibiotic treatment for animals is 
limited. 
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According to the most recent guideline for the treatment of Q fever in humans (2013), doxycycline is 
the drug of choice for acute Q fever in adults, children aged greater than 8 years, and patients with 
severe illness regardless of their ages. Doxycycline 200 mg per day for 14 days is recommended for 
acute infection (10). Fluoroquinolones, erythromycin, trimethoprim/sulfamethoxazole, and rifampin are 
alternative drugs (8, 10). Treatment is not recommended for asymptomatic individuals or for those whose 
symptoms have resolved (10). As infections can become chronic, recommendations on the follow-up for 
Q fever infections have been devised. Patients who are at high risk of developing chronic Q fever, 
including those who have valvular heart defects, aneurysms, vascular grafts, or pregnancies at the time of 
acute infection, should be monitored closely at 3, 6, 12, 18, and 24 months. Physical examinations and 
serological studies of phase I and phase II IgG and IgM antibodies should take place. If no evidence of 
rising phase I IgG antibody titers to 1:1024 or greater after 2 years and no clinical evidence of chronic 
infection such as endocarditis, vascular infection, or osteomyelitis occurs, serological monitoring could 
cease or be continued less frequently. For healthy acute Q fever patients with no identified risk factors for 
chronic infection, clinical and serological follow-up approximately 6 months after diagnosis should be 
performed. If the patient does not have serological or clinical evidence suggestive of the progression of 
chronic Q fever, follow-up can be discontinued.  
Treatment of chronic Q fever should not be based on serological results alone. Identification of 
potential organ infection should be performed if the patient develops any symptoms with evidence of 
phase I IgG antibody ≥ 1:1024. Doxycycline (100 mg twice daily) in combination with hydroxychloroquine 
(200 mg three times daily) is the drug of choice for treatment of chronic Q fever infection. Duration of 
treatment depends on the site of infection; for example, treatment is recommended for 18 months or 
longer in patients with chronic Q fever endocarditis. Serological follow-up of sera after treatment is 
required to determine treatment effectiveness. Cured chronic Q fever is defined as the patient having 
phase I IgG titers less than or equal to 1:200 (10).  
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THAILAND:  
Overview of the country  
Thailand is the third largest country in Southeast Asia, after Indonesia and Myanmar. It shares 
borders with the Lao PDR to the northeast, Myanmar to the north and northwest, Cambodia to the east, 
and Malaysia to the south. The country is administratively divided into 4 regions including north, 
northeast, central, and south (99). The annual calendar includes three seasons: summer (second half of 
February to mid-May), rainy (second half of May to mid-October), and cool (second half of October to 
mid-February) (100). The population was approximately 66,785,000 in 2011 (101). The majority of people 
work in agriculture, for example, rice and livestock farming (99). A public health infrastructure has been in 
place in Thailand for more than 70 years (99). To date, health care facilities are available nationwide, 
including hospitals at all provincial and district levels and health centers at the sub-district level. Universal 
health care coverage applies to all Thai people.  
 A national disease surveillance system was established in 1960 after a cholera epidemic. To date, 
there are 87 notifiable infectious diseases. These are divided into seven groups comprising food and 
water borne diseases, respiratory diseases, vector borne diseases, sexually transmitted diseases, central 
nervous system infection, vaccine preventable diseases, and zoonotic diseases. For zoonotic diseases, 
diseases under the surveillance system are rabies, leptospirosis, melioidosis, brucellosis, Streptococcus 
suis infections, avian influenza, and anthrax. Q fever is not currently included under the surveillance 
system.  
 
Q fever in Thailand and research gaps 
Q fever was first reported in Thailand in 1967 by a US-Southeast Asia Treaty Organization (SEATO) 
medical research study on rickettsial diseases (12). However, even today little is known about the 
disease. Q fever diagnosis in Thailand is limited. The serology test for Q fever diagnosis was not 
available before 2012. Laboratory capacity for Q fever diagnosis using IFA has been strengthened since 
2012 with the support from the Thai Ministry of Public Health – U.S.CDC collaboration (TUC). To date, 
five institutes can perform IFA for Q fever diagnosis. PCR for Q fever diagnosis is available at the national 
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level [National Institute of Health (NIH) and National Institute of Animal Health (NIAH)] and at some 
veterinary research centers and university hospitals.  
Because of limitations in laboratory diagnosis, as well as the low level of awareness among doctors 
and health personnel, few studies of Q fever have been conducted in Thailand. No studies explored risk 
factors associated with the disease. A study of the etiologies of acute fever in four hospitals from different 
regions of Thailand in 2001 – 2002 showed that Q fever was responsible for approximately 1% of the 
patients presented with acute undifferentiated fever (12, 14). Subsequently, in 2012, the first two cases of 
chronic Q fever endocarditis were reported in the northeastern region (13). The first case was a farmer 
who worked on a cattle farm, while the second was a patient with underlying aortic valvular heart disease 
who lived in an area surrounded by cattle farms. No additional studies were conducted to identify the 
possible source of infection (13). The most recent study published in 2014 showed that C. burnetii was 
responsible for approximately 8% (5/60) of patients with culture negative infective endocarditis admitted 
to Srinagarind Hospital, Khon Kaen, northeastern Thailand (102).  
Interest in Q fever research increased after the first two reported cases of Q fever endocarditis. In 
2012, a study of Q fever among ruminants with tuberculin positive results using the ELISA test in three 
districts of Chiang Mai Province found the seroprevalence of Q fever among cows was 4.8% (28/581) at 
the individual cow level and 62% (13/21) at the farm level (103). Furthermore, a different seroprevalence 
study showed the prevalence of Q fever was 15.6% (24/154) among 154 farmers and veterinarian-related 
personnel (16). Another study in Bangkok showed seroprevalence of Q fever among dairy cattle was 7% 
(9/130) and seroprevalence of Q fever among chickens was 1% (1/141)  Q fever surveillance of ruminant 
placentas in 2012 using PCR showed the presence of C. burnetii in beef, dairy cattle, goats, and 
buffaloes in 9 provinces from 3 regions of Thailand (15). In addition, a genotyping study from animal 
placentas showed positive results for strain ST18 in dairy cattle placenta (Pattarin et al., unpublished 
data). Strain ST18 was reported to be associated with acute disease in humans (17). This evidence 
suggests that Q fever might be endemic in Thai animals and that the burden of the disease in humans 
might be higher than expected.  
In Thailand, the dairy cow business is growing. The most recent report in 2014 by the Office of 
Agricultural Economics found that the number of dairy cows has increased every year since 2008  (104). 
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The majority of Thai farms are small to medium. Thus, all farms are either part of a dairy cooperative 
supported by the government or part of a private company. Considering that farmers work closely with 
animals and that the virulent strain is found in dairy cows, dairy farmers are one of the populations at 
greatest risk of acquiring Q fever.  
Since no study has been conducted to understand the magnitude and risk factors associated with Q 
fever, we proposed an epidemiological study to better assess the risk of Q fever, particularly among this 
high-risk population. The outcomes of this study can provide scientific evidence for the disease burden 
and factors associated with Q fever in dairy cattle farms and farmers. Following from these results, 
prevention and control strategies of Q fever can be established. 
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CHAPTER 3 
RESEARCH DESIGN AND METHODS 
Study design 
The main project was a one-year longitudinal study of dairy cattle farms and farmers conducted in 
Chiang Mai Province from June 2015 to August 2016. The study was conducted in three dairy 
cooperatives where Q fever was reported in 2012 and other two dairy cooperatives in adjacent areas. It 
was divided into three parts: 1) a prospective study among farmers, 2) screening bulk tank milk (BTM), 
and 3) field investigation of farms with positive BTM (Figure 1). The study included data and specimen 
collection at three time points every 6 months. This dissertation involves describing the study design and 
the analyses of baseline data of farms and farmers.  
 
P = positive, N = negative, S = suspect 
Figure 1. The cohort study protocol  
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There are two parts to the animal study: 1) bulk tank milk (BTM) screening for C. burnetii antibodies 
using ELISA at 3 time points including baseline with 2 more collections 6 months apart) (Figure 1: 
diagram in blue), and 2) field investigation on the farms with positive BTM to identify active shedders; this 
will provide information for the implementation of control measures and prevention (Figure1: diagram in 
green). Field investigation was conducted by the investigator in collaboration with public health and 
animal health officers. The investigation included vaginal swabs and blood collection from cows on the 
farms with positive antibodies in the milk. During the investigation, we provided health education 
regarding Q fever prevention to farmers and conducted active case finding. If the farmer had fever within 
one week, we collected a whole blood sample for PCR testing.  
Although Q fever transmission through milk is very rare, milk is a good and feasible sample to use as 
an indicator to detect Q fever infection in dairy animals as compared to feces and vaginal swabs. 
Previous studies show that, among infected cows, 38.0% of positive PCR samples were found in milk, 
32.3% in feces, and 29.7% in vaginal mucus (50). A study published in 2014 showed that cows shed 
bacteria mainly in milk and PCR positive milk is correlated with seropositivity in cows (105). Other studies 
have used BTM screening to detect farms with possible Q fever infection (80, 105, 106), but had never 
before been used in Thailand. Since our study used milk as the indicator for further investigation, it is 
possible that we might have missed some infected cows that did not secrete the antibody through their 
milk, or infected heifers, or infected cows that did not give birth during the study period. Nonetheless, this 
selection bias was minimized since previous studies had shown that cows shed the bacteria mainly 
through milk (50, 107) and the risk of Q fever in animals increases when age and parity number increases 
(74, 77).  
For the human study, a prospective cohort study among farmers on dairy cooperative farms at 3 time 
points was performed (Figure1: diagram in orange). Two farmers from participating farms were randomly 
selected. Individual information and serum samples were collected at baseline (month 0). Two additional 
follow-ups on clinical symptoms and blood samples at 6 and 12 months were performed. Milk collection 
was performed on the same day as specimen collection in humans.  
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Study area 
Previous seroprevalence studies among dairy farms registered in dairy cooperatives in Chiang Mai 
Province in 2012 showed evidence of seropositive Q fever in dairy farms in Sanpatong (6 out of 6 farms 
positive), Mae-on (2 out of 4 farms positive), and Mae-wang districts (5 out of 11 farms positive) (103). In 
addition, a serosurvey of Q fever among dairy farmers in the three dairy cooperatives in 2012 showed the 
prevalence of Q fever among farmers was 16.7% (2/12) in Mae-on, 13.3% (4/30) in Sanpatong, and 0 
(0/11) in Mae-wang districts (Rodtian et.al. unpublished data). Therefore, the study was conducted on the 
dairy farmers in these three dairy cooperatives, and two other dairy cooperatives in adjacent areas. 
Chiang Mai was ranked as the province with the 5
th
 highest number of dairy cattle in Thailand in 2012 
(108). Most Chiang Mai farms are small to medium. All farms in this province join or sell their milk product 
either to dairy cooperatives or private companies. Since a dairy cooperative is a local business open to all 
farms using the same business agreement, farm members of each dairy cooperative can come from any 
area. The Chiang Mai provincial livestock office has registered 9 diary cooperatives. The report of the 
Department of Livestock Development in May 2014 notes that a total of 1,004 dairy farms existed in 
Chiang Mai, with 796 farms registered to 9 dairy cooperatives (79.3%) (109). The farms from 5 dairy 
cooperatives involved in this study accounted for 44.9% (451/1,004) of all farms and 45.6% 
(15,995/35,054) of all cows in Chiang Mai Province (109).  
The farm members of the dairy cooperatives in our study come from 10 districts: Mae-on, 
Sankampaeng, Sansai, Doi-saked, Mae-rim, Mae-taeng, Sarapee, Sanpatong, Mae-wang, and Doi-lor 
(Figure 2).    
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 Mae-on District covers an area of approximately 442 km
2 
with a population of 21,363 people in 2012. 
The majority of people work on livestock farms, particularly dairy farms (110). Sankampaeng is a 
suburban district, adjacent to Mae-on. It covers 197.8 km
2
 and had a population of 79,072 in 2012. The 
majority of population work  on farms growing crops such as rice  and fruits, and on dairy cattle farms 
(111). Doi-saked is a district adjacent to Mae-on and Sankampaeng, covers an area of approximately749 
km
2
 with a population of 70,282 in 2012. The majority of people work on rice and fruit producing farms. 
Sansai district covers an area of 285.0 km
2
with a population of 114,223. The majority of people there 
work on rice and potato farms. Mae-rim is a district to the west of Sansai. It covers an area of 495 km
2
 
with a population of 81,047. The majority of people work on non-livestock farms that produce vegetables 
and rice. Mae-taeng covers an area of 1,326.78 km
2
 and had a population of 75,538. The majority of 
people work on  rice and fruit farms (111). Sarapee district covers an area of 97.45 km
2
, and had a 
population of 75,454. The majority of people work on non-livestock farms (111). Sanpatong district covers 
an area of 178.18 km
2
 with a population of 75,875. The majority of people work in non-livestock farms 
such as rice and tobacco farms (111). Mae-wang district is the area to the west of Sanpatong district. It 
covers an area of 601.68 km
2
, and had a population 31,045. The majority of people work in non-livestock 
Figure 2. Study areas and study cooperatives, Chiang Mai Province, Thailand (1: Mae-on, 2: 
Sankampaeng, 3: Doi-saked, 4: Sansai, 5: Mae-rim, 6: Mae-taeng, 7:  Sarapee, 8:Sanpatong, 9: 
Mae-wang, 10: Doi-lor 
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farms such as rice farms. Doi-lor is the district to the west of Mae-Wang, covering an area of 219 km
2
, 
with a population of 26,975. The majority of people work on fruits and rice farms (111).  
 
Study population 
The study subjects included dairy farms, cows, and all adult farmers who work in the participating 
farms of the five dairy cooperatives.  
Animals: The population was divided into two levels, the individual cow and the farm. In Thailand, all 
dairy cooperatives are registered to two government organization: the Cooperative Promotion Department 
and the Department of Livestock Development (DLD). The DLD is responsible for milk quality control and 
animal health. In 2013, there were 98 dairy cooperatives nationwide, with approximately 26,000 farm 
members or 80% of all the dairy farms in Thailand (112). This study included 5 out of 9 (55.6%) dairy 
cooperatives in Chiang Mai province. Dairy farms registered at any of the five dairy cooperatives before 
June 2015 were eligible for the study. Data from a May 2014 DLD survey is presented in Table 1. 
 
Table 1. Number of farms and dairy cows by dairy cooperative (Data from Chiang Mai Provincial livestock 
office report, May 2014) 
 
Dairy cooperative Number of farms Number of dairy cows 
Coop1 136 4,357 
Coop2  113 4,055 
Coop3 81 3,063 
Coop4 61 2,566 
Coop5 60 1,954 
Total 451 15,995 
 
The Department of Livestock Development has specified three categories of farm size: small (number 
of cows less are 20 or lower), medium (number of cows between 21 – 100), and large (the number of 
cows greater than 100) (108). Data from the Chiang Mai Artificial Insemination and Biotechnology 
Research Center in 2012 showed that the majority of the farms in the five dairy cooperatives are medium 
size farms (113). Coop1 had no large farms, 71 (60.2%) medium farms, and 47 (39.8%) small farms; 
Coop2 had 6 (3.1%) large farms, 139 (72.0%) medium farms, and 48 (24.9%) small farms; Coop3had 1 
(1.9%) large farm, 31 (58.5%) medium farms, and 21 (39.6%) small farms; Coop4 had 1 (1.5%) large 
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farm, 44 (65.7%) medium farms, and 22 (32.8%) small farms; and Coop5 had no large farm, 44 (62.0%) 
medium farms and 27 (38.0%) small farms (113).  
Each farm has one unique bulk tank milk (BTM) number. Farmers sell BTM to the dairy cooperative 
daily. The cooperative tests the BTM from all the farms for milk quality assurance including somatic cell 
count and antibiotic contamination.  
Humans: No information was available at the dairy cooperatives on the number of farmers. However, 
the local animal health officer, in an interview, stated that there were approximately 2 – 5 farmers per 
farm because the majority of farms in the study areas are small to medium. Any person 18 or older who 
worked on the participating farms when the study was conducted were eligible to be in the study.  
Since the study population was specific to dairy farms and farmers of the five dairy cooperatives, 
extrapolation of results to other farms in the Kingdom or elsewhere might be limited. Nonetheless, the 
results from this study, which highlight the risk of Q fever for this specific group, can be beneficial to other 
dairy cattle farms in the country because more than 80% of these farms are part of dairy cooperatives. In 
addition, the study might be useful for other settings with similar farm practices.    
 
Eligibility criteria  
All farm members of the five dairy cooperatives are qualified. Dairy farmers whose age was 18 years 
or older, worked on a farm in the five dairy cooperatives, had no contraindication for drawing blood such 
as infected or scarred tissues, and were willing to participate in the study were eligible to be included in 
the study. A dairy farmer was defined as any person who worked in the dairy farms regardless of gender 
or job description. For the study in cows (the farm investigation), all cows on the farms for which the milk 
tested positive for C. burnetii antibodies were eligible.  
 
Enrollment procedure  
A meeting between the investigators and all stakeholders including dairy cooperative managers, 
public health and animal health officers in the study areas, and public health and animal health officers 
from the Chiang Mai Provincial Health Office and Chiang Mai Provincial Livestock Office was arranged to 
discuss the project and solicit feedback from these stakeholders. After the cooperatives agreed to 
25 
participate, separate meetings between the investigators and farmers were conducted to provide health 
education regarding Q fever and to inform them about the project. Lists of dairy cooperative farm 
members were made available from the dairy cooperative offices. The number of farmers on each farm 
was obtained from a short survey taken during the meeting. Two stage probability sampling was 
conducted to select farms and farmers. Selected farms and farmers were contacted later by telephone. 
Data collection dates and times were arranged after these farmers agreed to participate in the study. 
 
Sampling methods 
We selected dairy cooperatives based on the evidence of Q fever from the previous study (103) and 
two other dairy cooperatives in their neighborhoods. Two-stage probability sampling was performed for 
the cohort study among farmers. The primary sampling unit was the farms on the list provided by the dairy 
cooperatives. To select the farms, we used stratified sampling according to farm size. The farms were 
stratified into three categories: 1) farms with 1–20 cows, 2) farms with 21–40 cows, and 3) farms with > 
40 cows. All farms in the third category and 50% of the farms in the first two categories were selected. 
This method took into account differences in farm size. From the selected farms, we planned to randomly 
select two farmers.  
The advantages of our sampling strategy were to increase specificity and to improve feasibility. Our 
study was specific to a high risk population since we created a specific cohort of dairy farmers. 
Consequently, specific prevention and control could be implemented. Moreover, this design was feasible 
since Chiang Mai Province has a well-established ‘One Health team’ which includes networks of both 
animal and public health professionals. As a result, the dairy cooperatives were more likely to agree to 
participate in the study. Two-stage sampling within the dairy cooperative allowed us to infer the results for 
all farms and farmers within these dairy cooperatives. The disadvantage of the purposive sampling was 
because it was non-probability sampling; thus we could not generalize the results to dairy farms and 
farmers in other areas or to the general population. Nevertheless, the study among this specific 
population can generate new knowledge of Q fever among high risk people in Thailand. Therefore, it can 
provide policy makers with scientific evidence of Q fever prevention and control.  
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Data collection 
Data were collected as follows concerning dairy cattle: 1) bulk tank milk (BTM) screening for 
antibodies to C. burnetii using ELISA at 3 time points including baseline and 2 follow-ups at 6 month 
intervals, and 2) field investigation on farms with positive BTM. Field investigation included blood and 
vaginal swabs collected from 8 cows on each of the positive farms. We provided health education about 
Q fever prevention and control to farmers during the farm visit. We also collected whole blood samples for 
a PCR test if the farmer had had fever within 7 days before the visit; this whole blood was collected to 
identify for C. burnetii DNA using real time PCR. For a cohort study among farmers, face-to-face 
interviews were conducted by trained interviewers using tested questionnaires to collect exposure data 
from all farmers who participated in the study. Data and sample collection of farmers were conducted at 
the same time as the BTM screening. 
- Exposure assessments 
Two questionnaires, a questionnaire to measure exposure history of each farmer and one to assess 
farm practice and farm management were used to assess farm exposure. These were developed and 
tested with the group of farmers in the study area before they were used to assure that the questions 
were clear and easy to understand. A face-to-face interview was conducted by trained interviewers using 
the tested questionnaires. All participating farmers were interviewed about their job descriptions and other 
exposure history on the farm. Farm owners or farm representatives were also interviewed about farm 
practices and farm management using the questionnaire.  The interviews were conducted 3 times – at 
baseline and two follow-ups at 6 month intervals. The interviewers were health officers and nurses. 
Training sessions on the questionnaire and the interview were held before data collection to ensure that 
all interviewers understood the questionnaire and procedures. 
The exposure assessment was divided into three components: animal, human, and ecological.   
1) Animal component:  
o Bulk tank milk number and the somatic cell count 
o Demographic information on cows: ages and breed 
o Reproductive history: number of parity, history of abortions, stillbirths, having weak 
offspring, placenta retention, and metritis 
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o Length of stay on farm, such as newly moved to or born and raised on the farm 
o History of antibiotic use for 2 months before interview 
2) Human component: since the data were collected 6 months apart, exposure history was an 
estimation of the history in the past 6 months before the interview.  
o Demographic information: age, gender, address, occupation, educational level, 
underlying diseases, and pregnancy status for women.  
o History of exposure to cattle: job descriptions and personal protective equipment used on 
the farm such as masks and boots. Previous studies showed that Q fever infection is 
dose dependent, hence, the average duration of exposure to cows (days/week and 
hours/day) was collected.  
 Definition of main exposure: close contact with cow secretions, particularly 
attending calving, and handling cow’s birth products. Exposures were classified 
as binary variable (yes or no), as well as the degree of exposure, defined by the 
number of cows farmer helped with calving, hours of work per day, and days per 
week. 
 Other exposure covariates: milking and culling 
o History of exposure to other animals and other possible risk factors: history of raising or 
having any of these animals: dogs, cats, rats, chickens, ducks, and history of abortion 
among them, history of traveling to other animal farms, histories of tick bites, drinking raw 
milk, cooking and eating raw placenta, and receiving blood transfusions.  
o Clinical signs and symptoms such as fever, headache, myalgia, fatigue, nausea, 
vomiting, abdominal pain, jaundice, cough, dyspnea. Moreover, laboratory information 
such as complete blood count, liver function test, and chest X-ray were extracted from 
the medical record review if the patient has visited the hospital.  
o History of antibiotic use one month before the interview: name of antibiotic, dosage, and 
duration of antibiotic use. 
3) Ecological component: other studies have shown that environmental factors such as farm 
practices, other animals raised on the farm, and wind direction were associated with Q fever 
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infection (39-41). Therefore, information regarding these ecological factors was gathered by 
interview and data extraction. We collected information at baseline and at the follow-ups 
every 6 months. Ecological factors and data sources include: 
o Farm characteristics: e.g., number of cows on the farm, number of farmers, duration of farm 
business. These data were obtained from interviews with farmers and a review of the district 
livestock office logbook.   
o Practices in the farm: e.g., having loose housing in the stable, no quarantine of newly 
purchased animals coming onto the farm, cleaning practices, and tick control practices. This 
information was gathered by interviews with the farm representative. 
o The main exposure of interest for the farm study was cleaning practices in the birthing area 
right after birth. The degree of exposure was classified into binary variables (yes or no) and 
categorical variables such as never, rarely, sometime, often, always etc.   
o Geographical location of the farm and other animal farms in the area. This information was 
obtained from the provincial livestock office and during the farm visit. 
o Number and types of animals raised on the farm: for example dogs, cats, chickens, and 
vaccines used on the farms. This information was obtained from interviews with farmers.  
o We planned to collect meteorological factors such as wind patterns and humidity during the 
study period. Unfortunately, no meteorological stations are located in the study areas.  
 
- Outcome assessment 
Study outcomes were evaluated at baseline (month 0) and 6 and 12 month intervals. For the human 
study, interview and blood collection for IFA was performed at 3 time points. If a farmer had a fever 
without an antibiotic administration within 7 days before the interview, whole blood samples were 
collected for the PCR test. The outcomes of interest are Q fever infection in humans and animals, 
determined by clinical presentations and laboratory results. Definitions of Q fever infection in humans 
were adapted from the US National Notifiable Diseases Surveillance System (64) and classified as 
follows: 
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Clinical suspicion of acute Q fever: any person who had a fever and at least one of the following signs 
or symptoms: severe headache, pneumonia, acute hepatitis, or elevated liver enzymes. 
Confirmed acute Q fever infection: a person who had clinical suspicion of acute Q fever and a four-
fold increase in IgG specific antibody titer to C. burnetii phase II antigen by indirect immunofluorescence 
assay (IFA) or had a PCR positive for C. burnetii DNA. 
Probable acute Q fever infection: a person who had clinical suspicion of acute Q fever and a single 
serum of IgG antibody titer to C. burnetii phase II antigen ≥ 1:128 by IFA. 
Suspected acute Q fever infection: clinical symptoms compatible with clinical suspicion of acute Q 
fever and had IgG antibody titer to C. burnetii phase II antigen ≥ 1:64 by IFA. 
Asymptomatic infection: a person who did not have fever during the study period and had a four-fold 
increase in the IgG specific antibody titer to C. burnetii phase II antigen by IFA. 
Q fever seropositive: an individual who had a single serum of IgG antibody titer to C. burnetii phase II 
antigen ≥ 1:64 by IFA. 
Laboratory confirmation of chronic Q fever infection: any farmer who had serum of IgG antibody titer 
to C. burnetii phase I antigen ≥ 1:800 by IFA. 
Laboratory suspect of chronic Q fever infection: any farmer who had IgG antibody titer ≥1:128 and 
<1:800 to C. burnetii phase I antigen by IFA. 
 
Outcomes of the animal study were assessed from laboratory results through BTM screening using 
ELISA at the farm level and ELISA and PCR tests at the individual cow level. BTM screening was 
performed two times. We recollected and retested BTM samples from farms with positive or suspected 
BTM found at the first screening. Definitions of the outcomes of interest in animals were defined as the 
following: 
Farm with active Q fever shedder: farm had evidence of C. burnetii DNA from vaginal swabs using 
PCR.  
Farm with evidence of Q fever infection: farm had evidence of C. burnetii antibody in milk using 
ELISA.  
C. burnetii seropositive: cow tested positive for antibody to C. burnetii by ELISA. 
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Active Q fever shedder: cow had positive C. burnetii DNA from vaginal swabs using PCR. 
BTM negative result: BTM tested negative at the first screening using ELISA. 
BTM positive result: farm with a first positive and positive or suspected positive second test and with 
suspected first test and positive second test. 
BTM uncertain result: farm with first suspect and suspect or negative second test and with first 
positive and negative second test.   
 
Laboratory procedures and quality control 
- Specimen collection, storage and shipment   
Data collection dates were arranged when farmers agreed to participate in the study. Participants 
were interviewed and had blood drawn on the same day. Specimen collections were performed at 3 time 
points: baseline and 2 additional follow-ups at 6 month intervals. Five milliliters of blood were collected 
each time by well-trained nurses using sterile techniques and stored in clot blood tubes before 
transferring to Maharaj Nakorn Chiang Mai Hospital on the same day they were collected. Sera were 
extracted and stored at Maharaj Nakorn Chiang Mai Hospital’s laboratory below -20°C. Sera were later 
transferred to Thai-NIH for IFA testing. All human sera were tested for IgG and IgM antibodies to C. 
burnetii phase I and phase II antigen. In addition, if the participant had had a fever within 7 days before 
the interview, 5 ml of blood were collected in Ethylene diamine tetraacetic acid (EDTA) tubes for PCR 
testing. 
All the BTM samples were screened at 3 time points, 6 months apart using ELISA. Twenty milliliters 
of milk from the BTM were collected at the dairy cooperatives in the morning by a research assistant on 
the same day or within one week of data collection of the farmers. All milk samples were labeled and 
transferred to the Veterinary Research and Development Center in ice boxes on the same day the 
specimens are collected. If the milk was positive, blood specimens for ELISA and vaginal swabs for PCR 
from 8 cows on that positive farm were collected. In addition to specimen collection from cows, sera of 
domestic animals such as dogs and cats raised on the farm and from cow ticks were collected to evaluate 
the existence of Q fever infection. Animal blood samples were tested for C. burnetii antibody using ELISA. 
Ticks were collected to identify the species and the presence of C. burnetii by Polymerase Chain 
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Reaction (PCR). Laboratory tests for all animal specimens were performed at the Veterinary Research 
and Development Center (Northern Region) in Lampang Province.  
Specimen collection in animals and humans was performed by trained veterinarians and nurses. 
Laboratory analyses were performed by trained technicians following industry and CDC guidelines for 
ELISA and IFA respectively. In addition, PCR studies were validated following US-CDC protocol.   
 
- Q fever diagnostic testing   
(1) Molecular Detection of C. burnetii 
Polymerase Chain Reaction (PCR) is a useful tool and has become more popular for Q fever 
diagnosis because it provides a result in a timely fashion (63). Previous studies have shown that using 
PCR to detect C. burnetii DNA is more sensitive within the first week after a fever (10). Therefore, blood 
specimens from farmers who had a fever one week before the interview were collected in EDTA tubes. 
Real time PCR was used to detect the evidence of C. burnetii DNA.  ehT transposase gene of insertion 
element, IS1111, of C. burnetii was the target gene. Previous studies showed that IS1111 is the sensitive 
target for PCR since they identified 75 isolates of C. burnetii from all over the world (114). Real time PCR 
was performed at Thai-NIH, following the protocol of the Q fever Laboratory, Ricketsial Zoonoses Branch, 
Division of High Consequence Pathogens and Pathobiology, National Center for Emerging and Zoonotic 
Infectious Diseases, US-CDC. The forward primer was 5’‐ccgatcatttgggcgct‐3’ and the reverse primer 5’‐
cggcggtgtttaggc‐3’. The hybridization probe method was used in real time PCR and the probe sequence 
was 5’‐ttaacacgccaagaaacgtatcgctgtg‐3’ (115). Strand-specific detection using a labelled nucleic acid 
probe enhanced specificity of the PCR since the probe demonstrated the presence of the target 
sequence. 
Vaginal secretion from vaginal swabs, swabs from the birthing area, soil, leftover food, whole blood 
samples from other animals on the farm, and ticks were tested using real time PCR. DNA extractions 
were performed using a Qiagen QIAmp kit, following the Qiagen Standard Tissue Extraction Protocol. 
Real time PCR for all animal and environment samples was performed at the Veterinary Research and 
Development Center (Northern Region), using the same protocol as for humans.  
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(2). C. burnetii Serology
 
 
Indirect Immunofluorescence Assay (IFA) is the current reference laboratory method for Q fever 
serological diagnosis. IFA can detect both phase I, a virulent form found in subjects with chronic infection, 
and phase II, a non-virulent form found in patients with acute infection (10). The capability to perform IFA 
for Q fever diagnosis was developed in Thailand in 2012 with support from the US.CDC. The C. burnetii 
phase I and phase II antigens used for IFA slides were the synthesis of C. burnetii Nine Mile strain. IFA 
were performed following the US.CDC protocol. Our study determined the presence of IgG and IgM 
specific antibody to C. burnetii for both phase I and phase II antigen. Serological positive results were 
defined according to the case definitions mentioned previously in the outcome assessment section (64).  
The Enzyme-Linked Immunosorbent Assay (ELISA) test has become more popular tool for use in 
serological surveys for Q fever since it has high sensitivity and specificity and is easy to perform (8, 10). 
ELISA has also been used for milk screening in other studies, which found that ELISA results 
corresponded with PCR results and can be a good tool for screening at the population level (105, 107). 
ELISA kit (IDEXX CHECKIT™ Q-fever Test Kit) was used for the serological study in milk and cow sera. 
The tests were carried out at the Veterinary Research and Development Center in Lampang Province 
following industry protocol.   
 
Data management and analysis 
Data management and quality control 
Interviewers were trained about the questionnaire before interviewing to ensure the quality of data 
collection. Questionnaires were rechecked for completeness after the interview by research assistants. 
Data were entered using EpiData3.1 (EpiData Association, Odense, Denmark).  Data checking and 
cleaning were conducted. If there was a missing value or uncertain information, we rechecked the 
questionnaire or communicated with the participants to make sure that the information was correct or 
changed, as appropriate. Quality control for laboratory methods followed standard criteria of the reference 
laboratory.  
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Data analysis 
Data and sample collection started in June 2015 and finished August 2016. Laboratory work was 
delayed from the planned schedule. Therefore, this dissertation focusses only on the analyses of the 
baseline data. 
Aim1. Describe the burden and factors associated with Q fever in dairy cattle farm 
1.1 Describe farms with Q fever positive in BTM and prevalence of Q fever in dairy cattle on the farms 
with positive BTM. 
To illustrate the magnitude of Q fever among dairy cattle farms in the five dairy cooperatives, the 
proportion of farms according to the ELISA results were calculated from the BTM screening data. 
Characteristics of these farms, such as number of cows, number of other animals, and farm practices by 
BTM results were calculated. Prevalence and 95%CI were calculated using sampling weight. Sampling 
weight was calculated from the number of eligible farms divided by the number of selected farms. Since 
only cows on farms with positive BTM were further investigated, the proportion of individual cows testing 
positive among all the cows being tested was calculated. Within-herd seroprevalence was also 
calculated. Clinical manifestations and characteristics of cows with serological positive and vaginal swab 
positive and negative were portrayed. In addition, geographical distribution of the farms and 
environmental factors such as distance from the positive farms were explored.  
 
1.2 Identify factors associated with the prevalence of C. burnetii antibody in BTM.  
BTM was used as the indicator for C. burnetii infection at the farm level. To identify factors associated 
with prevalence of C. burnetii antibody in BTM, logistic regression was used to estimate the odds ratio 
(OR) and 95% confidence interval (CI). A literature review was performed to determine the factors that 
might be associated with C. burnetii infection. Distances from the farms with positive BTM were calculated 
using ArcGIS. Univariate analysis of each variable controlling for sampling variables (cooperative and 
farm size) was performed. Variables with p-value ≤ 0.2 were considered important. Collinearity between 
variables was assessed and only informative variables were included in the multivariate analysis.  The 
age and number of cows on the farms were reported as significant factors associated with the prevalence 
of C. burnetii; hence, these variables were always included in the model. In addition, sampling variables 
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including cooperative and farm size were always included in the multivariate analyses. Since the number 
of cows and farm size were highly correlated, only farm size was included in the model. Manual backward 
elimination was performed. The Likelihood Ratio Test (LRT) was performed to determine the importance 
of included variables in the model and a p-value < 0.05 was considered significant.  An ecological fallacy 
was possible since the analysis only involved group level data, such as environmental factors and farm 
management practices; individual data were unavailable for analysis. Nevertheless, this objective 
underscored the potential factors associated with the prevalence of C. burnetii infection at the farm level, 
which is crucial in terms of prevention and control.   
 
Aim2. Describe the burden and factors associated with Q fever among dairy farmers  
2.1 Describe the prevalence, incidence, and clinical spectrum of Q fever among dairy farmers  
The outcomes of interest were the seroprevalence of C. burnetii infection and prevalence of Q fever 
among farmers. Definitions of seropositivity and Q fever infection have been mentioned above.  The 
prevalence of seropositive individuals were those who had IFA positive results regardless of clinical signs 
and symptoms at baseline. The prevalence proportion was calculated using the number of prevalent 
cases as a numerator and the number of the study population as a denominator.   
Descriptive statistics (frequencies, mean, standard deviation, median, interquartile range, maximum, 
and minimum) concerning cases and exposure variables by person, place, and time were performed. The 
geographical distribution of cases by farms, number of dairy cattle, and other possible sources of 
infection, such as other animal farms were explored.  
 
2.2 Identify factors associated with Q fever among dairy farmers and their family members 
To determine factor(s) associated with seropositivity among farmers, the Generalized Estimating 
Equation (GEE) model was applied. Since Q fever infection among the farmers working on the same 
farms could be influenced by both individual factors, such as age, gender, and underlying health 
conditions, and group factors, for example, the number of C. burnetii reservoirs on the farm and the 
proportion of active shedder animals, an independent assumption for traditional regression was violated.  
GEE is a statistical model to deal with correlated data by modeling the covariance structure. The GEE 
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provides a population average of the effect as a function of covariates over group-to-group heterogeneity, 
while accounting for within group non-independence of observations. The GEE requires a sufficiently 
large number of clusters for a robust estimation of standard errors. The benefit of GEE is that it allows 
robust inference even if the correlation model is mis-specified (116).   
Each farm has a unique tank number which was used as a unique identifier. The main exposure of 
interest was assisting in calving and coming into contact with a cow’s birth products. Univariate analyses 
controlling for sampling variables were conducted. Variables with GEE type 3 p-value ≤ 0.20 were 
considered important and were included in the multivariate analysis. Farm variables (aim 1.2) such as 
cleaning practices, proximity to positive farms, and BTM results were also incorporated into the analysis. 
Confounder assessment was performed using the change in beta estimation of the main exposure to the 
outcome in the full model compared to the reduced model or |βfull – βreduced|. The estimate of the main 
exposure in the full model is the gold standard. Change greater than 10% meant that the variable 
dropped from the full model (the reduced model) was a potential confounder; hence, that variable was 
kept in the model. The covariate with the highest p-value in the full model would be dropped first. The 
Odds Ratio (OR) and the 95% confidence interval (CI) were estimated from the model. Data analyses 
were performed using SAS version 9.3. 
Possible challenges and plan:  
- The study is subject to measurement errors as the outcome specification is based on serological 
tests which depend on the immune responses of each individual and the sensitivity and specificity of the 
diagnostic tests. Therefore, outcome misclassification is possible. To account for measurement errors, 
sensitivity analyses using a different antibody cutoff titer will be performed. 
 
Sample size and power 
Sample size justification was performed using information from a previous study where the 
prevalence of Q fever among dairy farmers was 16% (16). The CSurvey program was used for sample 
size calculation (117). For sample size calculation for the whole project, estimated one year incidence of 
Q fever among farmers (seroconversion) was 1.6%, one-half length of the confidence interval as 1.6%, 
the level of confidence as 95%, the design effect of 2, and the number of farmers per farm as 2, the 
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Figure 4. Power analysis of the ecological study of Q fever in the dairy cattle farms 
number of clusters needed as 260 farms and 520 farmers. The expected C. burnetii seroprevalence 
among farmers at baseline was 16%. To account for prevalence at baseline, the sample size we needed 
was 310 farms and 620 farmers.  EPISHEET  was applied to estimate the power using the sample size 
calculated from the CSurvey (118). We assumed that the risk of C. buretii infection in un-exposed 
humans with no history of assisting in calving was 0.018, the ratio of unexposed to exposed was 1, alpha 
was 0.05, the expected RRs range was from 2.0 – 3.0, and the estimated power was   23% – 78% if the 
number of exposed farmers was 260 (Figure 3).  
 
 
For the animal study, to identify factors associated with C. burnetii infection in dairy cow farms (aim 
1.2), the prevalence ratio was estimated from the ecological data. The main exposure was cleaning 
practice right after calving. To calculate the power based on the number of farms we have from the study 
in humans, we assumed that 260 farms participated in the study, the ratio of exposed to unexposed farm 
was 1, the risk of Q fever in un-exposed farm was 0.05, alpha was 0.05, and the expected prevalence 
ratio ranged from 2 – 3, the estimated power was 32% - 79% (Figure 4).  
 
 
 
Figure 3. Power analysis of cohort study by relative risk and number of exposed subjects 
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Timeline 
The on-site project was initiated in May 2015 and baseline data collection started in June 2015. 
The first month was field preparation  
Table 2. Time line of the project 
 
 
Ethical considerations  
This project was reviewed and approved by the Institutional Review Board (IRB) of the 
Department of Disease Control, Ministry of Public Health Thailand, the University of North Carolina at 
Chapel Hill, and the U.S. CDC. Informed consent forms for individual farmers and each farm were 
used. On enrollment day, each farmer was informed about the project, potential risks and benefits, 
and given the consent form. Farmers were allowed to ask any questions they might have had 
regarding the project. Consents were obtained from farm owners and farmers before data and sample 
collection. This project was exempted from the Institutional Animal Care and Use Committee of the 
University of North Carolina at Chapel Hill review.  
 
Significant and impact 
This study was the first longitudinal study to explore the epidemiology of Q fever among dairy cow 
farms and farmers in Thailand. Considering its longitudinal design, we have evaluated the incidence and 
risk factors associated with Q fever infection. Therefore, the outcomes of this study can provide scientific 
evidence for Q fever prevention and control among the high risk Thai population. In addition, this study 
Project Aspect May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16
Study preparation
 Finalize study protocol and 
materials
Contact and prepare field work
Data collection
 Meeting with stakeholders 
e.g., public and animal health 
officers
 Train interviewers
 Sampling and recruitment
 Bulk tank milk surveillance Baseline 1st F/U
 Data and specimen collection 
in human
Baseline 1st F/U
 Laboratory work
Data management, analysis, 
and manuscript
 Data cleaning
 Data analysis
 Manuscript preparation
 Submit papers for publication
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has clinical implications as it will highlight clinical spectrums and possible factors associated with 
developing signs and symptoms of Q fever patients; hence, it can provide a guideline for physicians in the 
diagnosis of Q fever. The results of this study will be presented to the Thai infectious disease medicine 
council so that it can also improve physicians’ awareness of Q fever.  Moreover, this study demonstrates 
the importance of the “One Health principle” in which the capacity of Thai government partners including 
animal and public health sectors to conduct a field investigation and laboratory testing of Q fever will be 
strengthened.  
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CHAPTER 4 
COHORT PROFILE: A LONGITUDINAL STUDY OF Q FEVER AMONG DAIRY CATTLE FARMS AND 
FARMERS IN CHIANG MAI, THAILAND 2015 – 2016 
 
INTRODUCTION 
Q fever is a zoonotic disease, caused by Gram-negative intracellular bacteria Coxiella burnetii. It has 
a low infectious dose and is classified as a category B bioterrorism agent (1). It is capable of causing 
large outbreaks, which may result in high morbidity in humans and animals. It can also have serious 
economic impacts, as was reported in the Netherlands (3, 119). The main route of transmission is by 
inhalation of aerosols contaminated with the bacteria from infected animal secretions such as birth 
products. Coxiella burnetii can infect a variety of hosts such as humans, ruminants, dogs, cats, and ticks.  
Exposure to these animals can lead to a high risk of infection (4). Q fever can cause abortion and weak 
offspring in animals, and flu-like symptoms, pneumonia and hepatitis in humans (5, 6). In addition, it can 
cause chronic sequelae in humans including endocarditis in 1 – 5% and chronic fatigue syndrome in 10 – 
20% of the infections (7, 9, 10). Since the clinical manifestations of acute Q fever are non-specific, Q 
fever diagnosis relies on laboratory tests, particularly serology.  
Q fever was first reported in Thailand in 1966 by the US SEATO Medical Research Study on 
Rickettsial Diseases (120). However, little was known about it because Q fever diagnostic capacity was 
limited in Thailand. After two reported cases of chronic Q fever endocarditis in Thailand in 2012, 
laboratory capacities for Q fever diagnosis using Indirect Immunofluorescense Assay (IFA) and 
Polymerase Chiang Reaction (PCR) were strengthened with the support of a Thai Ministry of Public 
Health – U.S.CDC Collaboration (TUC). In 2012, a seroprevalence study of Q fever in ruminants and 
people who were occupationally exposed to animals in two provinces of Thailand using ELISA showed 
the seroprevalence to C. burnetii among farmers at 43% (68/159) in the northern and 3% (15/502) in the
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northeastern provinces (unpublished). In addition, the seroprevalence of C. burnetii in animals was higher 
in the North (5.5% vs 0%); however, the prevalence in sheep and goats was higher in the northeastern 
province (5.9% vs 1.0%). Another study in Chiang Mai found the seroprevalence of Q fever among 
farmers and livestock officers was 16% using IFA (unpublished).  
In Thailand, the dairy business is growing. The most recent report by the Office of Agricultural 
Economics found that the number of dairy cows has increased every year since 2008 (104). No previous 
study done in Thailand examined risk factors associated with Q fever infection. Therefore, the Bureau of 
Epidemiology, Ministry of Public Health (MOPH), Thailand, in collaboration with Chiang Mai provincial 
health and livestock offices, the Department of Livestock Development (DLD), the National Institute of 
Health (NIH), the National Institute of Animal Health, and the Thai-MOPH – US. CDC Collaboration (TUC) 
launched a longitudinal epidemiological study to quantify the risk and identify risk factors associated with 
C. burnetii infection among dairy farmers and the prevalence and factors associated with C. burnetii 
infection in dairy cattle herds. The aims of the study were to describe the prevalence, incidence, and 
factors associated with Q fever and C. burnetii seropositivity in dairy farmers, to describe clinical 
manifestations of Q fever cases, and to describe the prevalence and factors associated with C. burnetii 
infection in dairy cattle farms using milk as a proxy for C. burnetii infection at the herd level. In addition, 
the prevalence of C. burnetii infection and factors associated with C. burnetii shedding and C. burnetii 
seropositivity in cows on farms with positive milk were explored. The outcomes of this study provide 
scientific evidence for the burden and factors associated with Q fever in dairy cattle farms and farmers in 
Thailand. Further, these data aid the development of prevention and control policies for Q fever. 
 
COHORT DESCRIPTION 
Setting  
A longitudinal study among dairy cattle farms and farmers was conducted in Chiang Mai Province 
from January 2015 – December 2016. The study was conducted in five dairy cooperatives including three 
dairy cooperatives where Q fever was reported in 2012 (103) and two other dairy cooperatives in adjacent 
areas. Chiang Mai was ranked as the province with the 5
th
 highest number of dairy cattle in 2012 (108). 
Nine diary cooperatives were registered to the Chiang Mai provincial livestock office. According to a 
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report from the Department of Livestock Development in May 2014, a total of 1,004 dairy farms were 
registered in Chiang Mai with 796 farms registered to nine dairy cooperatives (79.3%). The farms in this 
study were part of the five study dairy cooperatives and included 44.9% (451/1,004) of all farms and 
45.6% (15,995/35,054) of all cows in Chiang Mai Province. The distribution of farms and cows by the 
study dairy cooperative is described in Table 3. 
 
Table3. Distribution of farms and number of cows by dairy cooperatives 
  Number of farms (number of cows) 
Cooperative 
Farm with  
1 - 20 cows 
Farm with  
21 - 40 cows 
Farm with  
> 40 cows Total 
Coop1 41(582) 54(1572) 38(2203) 136(4357) 
Coop2 24(331) 48(1381) 41(2343) 113(4055) 
Coop3 21(274) 33(1029) 27(1760) 81(3063) 
Coop4 7(115) 28(926) 26(1525) 61(2566) 
Coop5 16(204) 26(779) 18(971) 60(1954) 
Total 109(1506) 189(5687) 150(8802) 451(15995) 
 
Meetings between the investigators and all stakeholders including dairy cooperative managers, public 
health and animal health officers in the study areas, and public health and animal health officers from the 
Chiang Mai Provincial Health Office and the Chiang Mai Provincial Livestock Office were held in Chiang 
Mai from January 20
th
 – 23
rd
, 2015 to engage with stake holders and develop the project work plan. 
Separate meetings between the investigators and farmers from the five dairy cooperatives were 
conducted from March 16
th
 – 20
th
, 2015 to provide health education regarding Q fever and to inform them 
about the project. The study was divided into three parts: 1) a prospective study of farmers, 2) screening 
of bulk tank milk produced by each farm, and 3) field investigation of milk positive farms (Figure 5). For 
the farmer study (Figure 5: diagram in orange), randomly selected farmers who were willing to participate 
and agreed to have blood drawn were interviewed at 3 time points including baseline and two more 
follow-up points at 6 months and 12 month intervals after the baseline.  
The other two parts of the study in animals included screening of bulk tank milk (BTM) for the           
C. burnetii antibody using ELISA at three time points using the same time frame as the farmer study 
(Figure 5: diagram in blue) and field investigation on the farms with positive milk to identify the source of 
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C. burnettii. These were taken so that control measures and prevention could be implemented (Figure 5: 
diagram in green).  
 
Figure 5. A protocol of the study  
 
Eligibility criteria  
Farms, farmers, and cows in the five dairy cooperatives were eligible for the study. All Thai farmers 
who worked in the participating farms, whose age was 18 or older when the study was conducted, and 
had no contraindication for blood drawn were eligible. A dairy farmer was defined as any person who 
worked in the dairy farms regardless of their gender and job description. In addition, all cows on ELISA 
positive milk farms were eligible.  
 
Sample size and sampling 
Sample size justification was performed based on the results of a previous study where the 
prevalence of Q fever among dairy farmers was 16%.
16
 The CSurvey program was used for sample size 
calculation (117). The estimated one year incidence of seroconversion of C. burnetii infection among 
farmers was 1.6%. The half-length of the 95% confidence interval was specified as 1.6%, with a design 
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effect of 2, for an average of 2 farmers per farm. Hence, the number of clusters needed for the study was 
260 farms and 520 farmers. We assumed that the prevalence at baseline was 16% for a positive serology 
to C. burnetii at baseline. Thus, to account for the prevalence at baseline, we needed to screen a total 
sample size of 620 farmers from 310 farms at the beginning of the study.    
Two-stage sampling was used to select a farmer cohort. The list of farms was obtained from the 
databases of the dairy cooperative with the primary sampling unit as the farm. We selected farms using 
stratified random sampling. All the farms in the five cooperatives were divided into three categories based 
on the number of cows within the farms; 1) farms with 1–20 cows, 2) farms with 21–40 cows, and 3) farms 
with > 40 cows. All farms with > 40 cows were selected, about 50% of the farms with 21 – 40 cows were 
selected, and about 50% of the farms with 1 – 20 cows were selected so that ultimately 306 farms were 
randomly selected. Figure 6 showed the examples of farm by farm size. 
 
Figure 6. Examples of farm by farm size 
 
The second sampling unit was the farmer. Lists of farmers were obtained from a short survey during 
the meeting with farmers, in which we asked for lists of the number of farmers at their respective farms. 
The sampling of farmers was adjusted based on the number of farmers per farm we obtained after the 
survey. The number of farmers from the selected farms varied from 1 – 8. To account for the variation of 
number of farmers to reach the targeted sample size, all farmers were selected at farms with 1 – 3 
farmers; 3 farmers were randomly selected from farms with more than 3 farmers by simple random 
sampling and random digit number. Ultimately, 637 farmers were randomly selected.    
During the farm visit, 8 cows were selected as randomly as feasible to represent infection at the farm 
level. Sample size calculation was performed using the CSurvey program; the estimated seroprevalence 
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of C. burnetii infection in dairy cows was 15%, the estimated one-half length of the 95% confidence 
interval was 4%, the design effect was 3, and the number of clusters expected to have positive milk was 
115 farms. The numbers of cows needed per farm was 8.   
 
Data and specimen collection 
Selected farms and farmers were contacted by research assistants to arrange the date and time for 
data collection. Two questionnaires were developed and tested with farmers in the study area to insure 
that the questions were clear and easy to understand. One questionnaire, asking about the exposure 
history of each farmer, and a second questionnaire, assessing farm practice and farm management, were 
used for the interviews. A face-to-face interview was conducted by trained interviewers using both 
questionnaires to collect exposure data from all farmers on participating farms. In addition, farm owners or 
farm representatives were interviewed about farm management and farm practice. The interviews were 
conducted 3 times – at baseline and at 2 follow-up interviews 6 months apart using the same 
questionnaires. The interviewers included health officers and nurses who were trained before data 
collection to ensure that all interviewers understood the questionnaires. 
For Bulk Tank Milk (BTM) screening, farmers store milk in containers and sell it to the dairy 
cooperative in the morning and in the evening. Research assistants collected 20 ml of milk from 
containers on the morning of the same day or within one week of data collection of farmers. All milk 
samples were labeled and transferred to the Veterinary Research and Development Center at 
temperatures under 4°C on the same day that the specimens were collected. We recollected and retested 
BTM from farms with positive milk or suspect ELISA on the first screening.  
Field investigations were conducted by investigators in collaboration with public health and animal 
health officers in the area. Eight cows on each positive milk farm were randomly selected for blood draws 
and vaginal swab collection. Information for sampled cows such as breed, gravidity, and history of 
reproductive disorder were obtained by a review of the cow’s record and an interview with the farmer 
during the farm visit. A record card for each cow included its name, breed, and reproductive history. 
Moreover, a swab from the birthing areas, soil at the end of the sewage area, leftover food on trays, ticks, 
and blood from other animals in the farm were collected. Active case finding of farms with positive milk 
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was conducted to evaluate if the farmers had fever. Farmers who reported feeling ill or having fever were 
interviewed and clinical presentations were assessed by the researcher. If the fever occurred within 7 
days before the interview, a whole blood sample was collected for PCR testing. Only newly positive milk 
farms were visited.  
 
Ethical considerations 
The study protocol was reviewed and approved by the Institutional Review Board (IRB) of the 
Department of Disease Control, Ministry of Public Health – Thailand, and the University of North Carolina 
at Chapel Hill. Informed consents were obtained from farm owners and farmers before data collection. 
The baseline data were collected from June to August 2015, the first follow up took place from January to 
March 2016, and the second follow up was done from June to August 2016. 
 
Laboratory study 
- Serological study  
Indirect Immunofluorescence Assay (IFA) is the current reference laboratory method for Q fever 
serological diagnosis. IFA can detect antibodies against Nine Mile Phase I C. burnetii, which are typically 
found at high levels in subjects with chronic Q fever, and antibodies against Nine Mile Phase II  
C. burnetii, which are typically found in patients with acute infections (10). The capability to perform IFA 
for Q fever diagnosis was developed in Thailand in 2012 with the support of the US CDC. C. burnetii Nine 
Mile phase I and II antigens were provided by the US CDC. Human sera were kept at - 20°C before 
transfer to the Thai National Institute of Health (Thai-NIH) for IFA testing. IFA will be performed to 
determine IgM and IgG specific antibody to C. burnetii for both phase I and phase II antigens following the 
he US CDC. protocol (121).  
ELISA kits (IDEXX CHECKIT™ Q-fever Test Kit) were used for the serological study in milk and cow 
sera. The tests were carried out at the Veterinary Research and Development Center (VRDC) in 
Lampang Province following the industry protocol.  Optical Density (OD) was evaluated. Sample per 
Positive percentages (S/P%) was calculated by 100 x (ODsample – ODnegative control)/( ODpositive control - ODnegative 
control). The S/P% <30% was defined as negative, S/P% between 30% to less than 40% was defined as 
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suspect, and S/P% ≥ 40% was defined as positive. We collected second BTM samples from the farms 
with positive or suspect milk results to retest for C. burnetii antibodies using ELISA. Farms with the first 
positive and positive or suspected second test were defined as positive BTM. In addition, farms with a 
suspected the first test, and positive second test were also defined as positive BTM. BTM samples with 
negative ELISA results were defined as negative. The rest of the results were defined as uncertain.  
 
- Molecular Detection of C. burnetii 
Real time PCR was used to detect the evidence of C. burnetii DNA in cow placenta, vaginal 
secretion, other animal whole blood, soil, ticks, and swab from the birthing area in BTM positive farms. In 
addition, 50 milk samples from each round of sample collection were randomly selected for PCR analysis 
to determine the correlation between serological evidence for C. burnetii and C. burnetii shedding in milk. 
DNA extractions were performed using QIAmp
® 
genomic DNA and DNeasy
®
 kits (QIagen), following the 
QIagen Standard Tissue Extraction instructions. Real time PCR was performed at the Veterinary 
Research and Development Center, following the protocol of the Q Fever Laboratory, Ricketsial 
Zoonoses Branch, Division of High Consequence Pathogens and Pathobiology, National Center for 
Emerging and Zoonotic Infectious Diseases, U.S.CDC. The forward primer 5’‐ccgatcatttgggcgct‐3’, the 
reverse primer 5’‐cggcggtgtttaggc‐3’ and a hybridization probe 5’‐ttaacacgccaagaaacgtatcgctgtg‐3’ were 
used to amplify the transposase gene of the insertion element IS1111 of C. burnetii (115). DNase/RNase 
free water was used as a negative control and samples of previously confirmed C. burnetii DNA were 
used as positive control. PCR was performed using the Roche, LightCycler® 96 System. PCR positive 
was defined when the sample had typical amplification curves with a cycle threshold (Ct) value less than 
40. 
 
MEASUREMENTS 
Outcome assessment 
Outcomes of interest in farmers, milk, and cows are defined in Table 4. IFA tests were conducted on 
sera from all participating farmers throughout the study period. The outcome definitions for famers were 
based on clinical manifestations and IFA titer. Laboratory criteria were adapted from the case definitions 
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of Q fever infection in humans used by the US National Notifiable Diseases Surveillance System 
(NNDSS) (64). Outcomes in milk were defined according to the ELISA results. Milk-negative was defined 
as ELISA negative on the first test only. Milk positive was defined as a farm with the milk positive by 
ELISA two times, with a first test positive and suspect second test, or with a first test suspect and positive 
second test result. The remainders of the milk results were defined as uncertain. Cows in the farm with 
positive milk were randomly selected for blood drawn and vaginal swab collection. Seropositive cows 
were defined as the cows with ELISA positive according to the manufacture’s guideline. In addition, cows 
with PCR positive from vaginal swab samples were defined as active shedders.  
 
Table 4. Outcome definitions used in the study of the epidemiology of Q fever among dairy farms and 
farmers in Chiang Mai, Thailand 2015 – 2016  
 
Outcomes Definitions 
Farmer   
Clinical suspicion of acute Q 
fever 
Fever and at least one of the following clinical findings and 
signs: severe headache, pneumonia, or elevated liver enzymes 
Confirmed acute Q fever 
infection  
Clinical finding(s) & ≥ 4 increase in IgG specific antibody titer to 
C. burnetii phase II antigen, or PCR positive for C. burnetii DNA 
Probable acute Q fever 
infection 
Clinical finding(s) & single serum of IgG titer to C. burnetii 
phase II antigen ≥ 1:128  
Suspected acute Q fever 
infection 
Clinical finding(s) & phase II antigen  ≥ 1:64 
Asymptomatic infection No history of fever, but having ≥ 4 increases in the IgG 
specificantibody titer to either C. burnetii phase I or phase II 
antigen  
Seropositive to C.burnetii 
infection 
Single serum of IgG antibody titer to either phase I or phase II 
antigen ≥ 1:64  
Laboratory confirmation of 
chronic Q fever infection 
Serum of IgG antibody titer to C. burnetii phase I antigen ≥ 
1:800 plus a recognizable nidus of infection 
Laboratory supportive of 
chronic Q fever infection 
IgG antibody titer to C. burnetii phase I antigen ≥1:128 but 
<1:800 plus a recognizable nidus of infection 
Milk (BTM)   
Negative result Negative ELISA 
Positive result First positive ELISA and second positive or suspect, or first 
suspect ELISA and second positive 
Uncertain result ELISA positive/negative, suspect/suspect, and 
suspect/negative  
Non-positive result combination of negative and suspect BTM 
Cows   
Seropositive  Cows that tested positive for antibody to C. burnetii by ELISA 
Active Q fever shedder  Animals that have positive C. burnetii DNA using PCR 
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Exposure assessment 
Exposures of interest were divided into the individual famer level and the farm level (Table 5). 
Individual factors included demographic information, farmers’ job descriptions on the farm such as assist 
in birthing, milking etc., working experiences, working hours, use of Personal Protective Equipment (PPE) 
on the farms, and other potential risk factors. Examples of other potential risk factors included assisting 
other animal birthing and contact with other animals. For the farm, we obtained information on farm 
location, farm characteristics such as number of cows, breed, breeding, and farm management, for 
example cleaning practices, feeding systems, and tick control systems. In addition, the physical history of 
individual cows including age, breed, number of calves, and history of reproductive disorders were 
obtained during the farm investigation.  
 
Table 5. Summary of exposure variables collected for the study of Epidemiology of Q fever among dairy 
farms and farmers in Chiang Mai, Thailand 2015 – 2016  
 
Farmer Characteristics Farm Characteristics 
Demographic Characteristics Farm address 
 Age Location of the farms 
 Sex Number of cows 
 Address Breed/Breeding 
  Feeding system 
History of illness Air flow 
 Underlying diseases Floor/ bedding 
 History of abortion in women  
 Signs and symptoms one week before data 
collection 
Cow housing 
Cleaning practices in general and 
after calving 
 
Quarantine of newly purchased 
animals 
Working history Raising other animals in the farm 
 Assist in cow birthing Tick control practices 
 Contact with birth product  
 Milking 
  Cleaning stables 
  PPE such as gloves, use of masks, etc. 
 
  Other risk factors 
  Help with other animal births 
  Drink raw milk 
  Eat raw meat 
  Travel to other animal farms 
  Receive blood transfusion 
  Tick bite 
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PRELIMINARY FINDINGS AT BASELINE  
Among 306 randomly selected farms, 282 farms (92.2%) and 532 farmers from 637 randomly 
selected farmers (83.5%) participated in the study. In participating farms, the median number of farmers 
per farm was 2 (ranged from 1 – 8). The median number of cows per farm was 41 (ranged from 4 – 125). 
Approximately half of participating farms had more than 40 cows per farm (51.8%) and 34% and 14.2% of 
the farms had number of cows 21 – 40 and 1 – 20, respectively. Participation varied by farm size with 40 
out of 58 farms (69.0%) with 1 – 20 cows participating, 96 out of 98 farms (98.0%) with 21 – 40 cows 
participating, and 148 out of 150 farms (97.3%) with > 40 cows participating in the study. The response 
rate by coops showed 73/78 (93.6%) for coop1, 39/42 (92.8%) for coop2, 78/88 (88.6%) for coop3, 40/42 
(95.2%) for coop4, and 52/52 (100.0%) for coop5. The baseline seroprevalence of C. burnetii in milk was 
40.8% (115/282); the baseline seroprevalence of C. burnetii among farmers was 16.9% (90/532). Among 
115 farms with positive milk, 99 farms were visited and samples were collected from 790 cows. The 
seroprevalence to C. burnetii was 28.4% (224/790) at the individual cow level and 91.9% (91/99) at the 
farm level.  
 
STRENGTHS AND LIMITATIONS 
Our study was the first longitudinal study to determine the epidemiology of Q fever among dairy 
farmers in Thailand. Since information on Q fever in Thailand is limited, this study provided substantial 
information of C. burnetii infection among dairy farms and farmers. We examined the baseline information 
of Q fever in this high risk population as well as the clinical spectrum of Q fever and serological pattern in 
response to C. burnetii infection. Considering the longitudinal design, we were able to evaluate the 
incidence and risk factors associated with C. burnetii infection. Therefore, the outcomes of this study 
provide scientific evidence for Q fever prevention and control among the high risk populations in Thailand. 
In addition, this study highlights clinical spectrums and possible factors associated with developing signs 
and symptoms of Q fever patients in Thailand; hence, it provides a guideline for physicians to include Q 
fever as a differential diagnosis. The results of this study were presented to the Thai infectious disease 
medicine council to improve physicians’ awareness of Q fever. Moreover, this study demonstrated the 
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One-Health concept in which Thai animal and public health sectors can collaborate to conduct a field 
investigation and laboratory testing of Q fever.  
Since the study was conducted in a specific area in Thailand, generalizability of results to other areas 
might be limited. Nevertheless, the study in this specific population generated new knowledge of Q fever 
among a high risk population in Thailand. Moreover, the information can be useful for other farms with 
similar practices. As with other longitudinal studies (122), loss of respondents, in this case farmers, to 
follow-up meetings  was possible. To prevent these losses to follow-up, we explained the study protocol 
to farmers and answered any questions that they had on the enrollment day. In addition, we collaborated 
closely with dairy cooperatives to ensure that farmers were informed about data collection date and time. 
Moreover, measurement errors could be possible since our study assessed the antibody response to 
C. burnetii. The results of antibody level could depend on several factors such as the immune response of 
each individual, the laboratory methods, and the experiences of the laboratory staff. To minimize the 
measurement errors, our study used the same laboratory methods and same readers throughout the 
study. Moreover, to take the measurement errors into account, sensitivity analyses using different 
antibody cutoff values were performed to determine possible risk factors for the disease. 
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CHAPTER 5 
EPIDEMIOLOGY OF C.BURNETII INFECTION AMONG DAIRY CATTLE FARMS, CHIANG MAI, 
THAILAND 2015 
 
Introduction 
Q fever is a zoonotic disease, caused by obligate intracellular bacteria, Coxiella burnetii. It can infect 
a wide variety of hosts including humans, ruminants, dogs, cats, ticks, and wild animals (123). Q fever 
transmits mainly via aerosols. Ticks are suspected to be another source of infection in animals (124). 
Animals infected with C. burnetii are mostly asymptomatic. However, infection can cause reproductive 
problems in ruminants. Previous studies showed that abortions were more common in small ruminants 
such as goat and sheep. Metritis and infertility might be associated with Q fever infection in cattle which 
can last for several months (6, 46-48). Infected animals shed bacteria via birth products, milk, urine, and 
feces regardless of their clinical symptoms (6, 25). This shedding might persist for several months, 
especially in vaginal mucus, feces, and milk (26). Cattle and goats shed bacteria through milk more 
frequently than do sheep (27). C. burnetii infections are mostly asymptomatic in human; however, it can 
cause a “flu”-like illness, and some Q fever infections develop chronic sequelae including endocarditis in 
1 – 5%, and chronic fatigue syndrome in 10 – 20% (7-10). Since clinical manifestations of Q fever are 
nonspecific, the diagnosis of Q fever in both animals and humans relies on laboratory tests, particularly 
serology (10).  
Knowledge of Q fever in Thailand is limited. After the first reports of Q fever in Thailand in 1966 (120), 
some studies were conducted to understand the burden and risk factor for Q fever. Q fever research 
received more attention after the first two reported cases of human Q fever endocarditis in Thailand in 
2012 (13). In 2012, a study examined the presence of C. burnetii DNA in ruminants’ placenta from nine 
provinces of Thailand. This study showed the presence of C. burnetii DNA in beef, dairy cattle, goats, and 
buffalo (15). A separate study was conducted in 2012 – 2013 in two provinces, Chiang Mai and 
Nakornratchasima, to determine the seroprevalence to C. burnetii among occupationally exposed
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people and ruminants, using Enzyme Linked Immunosorbent Assay (ELISA) (manuscript submitted). The 
prevalence of C. burnetii seropositivity among farm workers with occupational exposure was 43% in 
Chiang Mai and 3% in Nakornratchasima. Seropositivity to C. burnetii was highest in dairy cattle (4.6%, 
45/988), followed by goats (3.5%, 18/516), and sheep (2.1%, 1/48).  Because knowledge of Q fever 
epidemiology in Thailand is limited, the Bureau of Epidemiology, Ministry of Public Health Thailand, in 
collaboration with Chiang Mai public health and animal health, the National Institute of Animal Health 
(NIAH), the National Institute of Health (NIH), and the Thailand Ministry of Public Health – U.S. CDC 
Collaboration (TUC) conducted a longitudinal study of Q fever among dairy cattle farms and farmers in 
Chiang Mai during 2015 – 2016. Here, we report baseline information to determine the percentage of 
dairy cow farms where cows show evidence of C. burnetii infection using antibodies in Bulk Tank Milk 
(BTM) as a surrogate outcome for C. burnetii infection at the herd level. Risk factors associated with C. 
burnetii infection on dairy cow farms were also determined.  
 
Methods 
Study design and study population 
This study was part of a one year longitudinal study of Q fever among dairy farms and farmers 
conducted in Chiang Mai Province; data were collected from June 2015 – August 2016. A full description 
of the cohort and study design was described elsewhere (manuscript submitted). In brief, a study was 
conducted in three dairy cooperatives of Chiang Mai where the evidence of Q fever was reported in 2012 
(17) and two other dairy cooperatives in the adjacent areas out of the total of nine dairy cooperatives in 
Chiang Mai. Farms were randomly selected from these five dairy cooperatives based on the number of 
cows on each farm. Farms were stratified according to the number of cows into three groups: 1) farms 
with 1–20 cows, 2) farms with 21–40 cows, and 3) farms with > 40 cows. All farms in category 3 were 
selected and 50% of farms from categories 1 and 2 were randomly selected. 
Sample size calculation for the project was based on the estimated incidence of seroconversion to C. 
burnetii among farmers, using the CSurvey program (117). We assumed that the estimated incidence of 
seroconversion to C. burnetii was 1.6% in one year, the half-length of the confidence interval was 1.6%, 
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the design effect was 2, and the number of selected farmers per farm was 2. The sample size for the 
farms after taking 16% seroprevalence among farmers at baseline into account was 310.  
 
Data collection 
Q fever was largely unknown to farmers. Meetings between the investigating team, local public health 
and animal health officers, and farmers were set up to inform farmers about the project and to provide 
health education regarding Q fever. Randomly selected farms were contacted by research assistants. 
Farm owners and workers provided informed consent before participating in the study.  The study was 
approved by IRBs at the Department of Disease Control, Ministry of Public Health – Thailand, the 
University of North Carolina at Chapel Hill, and the U.S. CDC. Face-to-face interviews with farm owners 
or farmers who knew about farm practices were performed by trained public health officers and nurses. 
Questionnaires were tested with farmers in the study area to ensure that the questions were clear and 
easy to understand. General information about the farm such as number of cows, breed, breeding 
methods, feeding systems, farm practices (i.e., cleaning, and personal protective equipment used in the 
farm), and farm management (i.e., waste management) were collected.  
Each farm registered with a Coop had its own unique Bulk Tank Milk number. Farmers sell milk to 
dairy cooperatives in the morning and in the evening. The research assistants collected 20 ml samples of 
BTM at the dairy cooperatives in the morning on the same day or within one week after the interview. All 
milk samples were labeled, stored in ice boxes, and transferred to the Veterinary Research and 
Development Center in Lampang Province (VRDC-Lampang) on the day they were collected.  
Farms with a positive BTM ELISA were further investigated to identify the possible source of the 
infection. During the farm visit, we collected sera and vaginal swabs from 8 cows per farm, swabs from 
the birthing area, soil at the end of the water drainage, leftover food on the tray, whole blood of other 
animals in the farm, and ticks if available. In addition, health education was provided to farmers regarding 
Q fever prevention.  
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Laboratory analysis 
Laboratory tests were carried out at the Veterinary Research and Development Center in Lampang 
Province (VRDC-Lampang). VRDC-Lampang is a regional branch of the National Institute of Animal 
Health where staff members are trained for C. burnetii testing. We used Enzyme Linked Immunosorbent 
Assay (ELISA) - IDEXX CHECKIT™ Q-fever Test Kit to detect antibodies in milk and cow sera. ELISA 
was performed following the IDEXX Q fever manufacturer’s protocol. ELISA results were determined 
according to sample by positive control percentages (S/P%) calculated from the optical density (OD) 
values (ODsample – ODnegative control)/ (ODpositive control – ODnegative control) x 100. The S/P% <30% was defined as 
negative, S/P% between 30% or more to less than 40% was defined as suspect, and S/P% ≥ 40% was 
defined as positive according to the manufacturer’s protocol. All BTM samples were first screened by 
ELISA. Farms with BTM suspected or positive results were retested using ELISA in new BTM samples.  
BTM positive was defined as farms with ELISA positive in both tests or positive in one and suspect in the 
second test. BTM negative was defined as ELISA negative from the first screening. All others were 
defined as uncertain.  
Vaginal swab samples, whole blood from other animals, soil, swabs from birthing areas, leftover food 
on trays, and ticks were tested for evidence of C. burnetii DNA using real time Polymerase Chain 
Reaction (PCR). DNA extraction was performed using QIAGEN ® following the manufacturer’s 
instructions. Real-time Taqman PCR was performed at the VRDC-Lampang following the protocol from 
the US CDC Q fever laboratory. The target gene was the IS1111 insertion sequence. The forward primer 
is ccgatcatttgggcgct and the reverse primer is cggcggtgtttaggc. The hybridization probe sequence is 
FAM-ttaacacgccaagaaacgtatcgctgtg-BHQ1 (115).  
 
Data analysis 
Data were entered using EpiData3.1 (EpiData Association, Odense, Denmark). Data cleaning and 
analyses were performed in SAS version 9.3 (SAS Institute, Cary, NC, USA). Only baseline information is 
reported in this paper. Descriptive statistics describing prevalence of the antibodies in BTM by farm 
characteristic, such as number of cows, breed, breeding, farm practices, and farm management were 
calculated. In addition, mean, median, and measures of dispersion including standard deviation, 
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minimum, maximum, and interquartile ranges were calculated for continuous variables. The prevalence of 
antibody to C. burnetii in BTM and its 95% Confidence Intervals (95%CI) were calculated using weighted 
estimates. Sampling weights were calculated using the number of eligible farms divided by number of 
selected farms.  
For farm investigation data, the antibody prevalence and prevalence of C. burnetii DNA were 
calculated at the individual cow and at the herd level. In addition, the median within-herd antibody 
prevalence and the median within-herd prevalence of C. burnetii DNA were calculated from the proportion 
of positive cows per farm. The proportions of positive test results were also calculated for environmental 
samples.  
The logistic regression method was used to estimate the Odds Ratio (OR) and the 95% Confidence 
Interval (CI) of factors associated with C. burnetii antibody positivity in BTM. We developed two logistic 
regression models comparing BTM positive vs. BTM non-positive (combination of negative and uncertain 
BTM results), and BTM positive vs. BTM negative. All exposure variables of interest were evaluated in the 
univariate analyses adjusted for sampling variables including cooperative and farm size. Variables with p-
value ≤0.2 in a univariate model were considered important and were included in the multivariate 
analysis. Exposure variables that met the criteria were assessed for their collinearity. If there was strong 
correlation between two exposure variables, only the variable that was more informative was included in 
the multivariate model. In multivariate logistic regression analyses, the manual backward stepwise 
elimination technique was applied. Sampling variables (dairy cooperative and farm size) were always kept 
in the model. Number of cows on the farm and age stratification of cows have frequently been reported as 
important factors in C. burnetii seropositivity in ruminants and were evaluated in the model (125, 126). 
Number of cows was explained by farm size. However, information about the cows’ mean or median age 
on the farm was not available. Therefore, we used the number of cows by age category to describe the 
age distribution of cows on the farm. Age of cows was divided into 3 groups: < 1 year, 1 to < 2 years, and 
≥ 2 years. The percentages for the number of cows by age group was calculated and included in the 
model to take into account the importance of the cows’ ages. Percentages for cow’s age were explored 
as both a continuous and categorical variable. The Likelihood Ratio Test (LRT) was performed to 
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evaluate the importance of included variables in the model and a p-value < 0.05 was considered 
significant.   
Farm location information was obtained from the Chiang Mai Provincial Livestock Office, as well as 
from the farm visit. The proportions of farms with positive BTM among all farms tested were calculated 
and portrayed. Spatial autocorrelation among BTM positive and BTM negative farms were examined 
using Moran’s I statistics. The distances from the nearest positive farms were calculated and assessed in 
the logistic model. Spatial analysis was performed using ArcMap10.3.1 (ArcGIS 10.3.1, Esri, Redlands, 
CA).  
 
Results   
Among 306 randomly selected farms, 282 farms participated in the study (92.2%). For the 24 non-
participating farms, 9 farms stopped their business and 15 farms were unwilling to participate. There were 
148 BTM’s with positive or suspect results at the first ELISA screening and 154 BTM with negative 
results. After the second ELISA screening, 115 BTM met the positive criteria and 33 farms had uncertain 
results.  
The overall prevalence of antibodies to C. burnetii in BTM was 38.98% (95%CI 32.91 – 45.05%). The 
prevalence was highest in coop1 at 55.16% (95%CI 42.99 – 67.34%), followed by coop2 at 37.36% 
(95%CI 25.53 – 49.18%), coop3 at 36.51% (95%CI 21.94 – 51.08%), coop4 at 25.69% (95%CI 7.91 —
43.47%), and coop5 at 22.48% (95%CI 7.64 – 37.32%) (Supplemental Table 1). The prevalence of 
antibodies to C. burnetii in BTM was higher on farms with higher numbers of cows in all cow age ranges. 
In addition, farms that used both artificial insemination and natural breeding had a higher prevalence of C. 
burnetii antibody compared to those using artificial insemination alone (79.04% vs 38.33 %).  
Prevalence varied on farms with different cow bedding types: farms using concrete with rubber mats 
had the highest prevalence (58.95%, 95%CI 39.80% - 78.11%), followed by farms with concrete only 
(40.68%, 95%CI 33.14% - 48.23%), and concrete and soil (19.576%, 95%CI 8.73% - 30.40%). Farms 
with separate birthing stables and separate stables for quarantine had a lower prevalence compared to 
those that did not.  
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The prevalence of BTM positivity was 47.35% (95%CI 39.46 – 55.25 %) in farms located within 1 
kilometer of other BTM positive farms and 23.52% (95%CI 9.62 – 37.41%) and 17.48% (95%CI 6.53% - 
28.43%) for farms within 1 –2 km and more than 2 km, respectively. Median length of farm business 
among positive farms was 18.5 years (range 1 – 40, IQR 6 – 21 years) and 13 years (range 1 – 43, IQR 
10 – 26 years) among non-positive farms. The median percentage of cows aged ≥ 2 years on milk 
positive farms was 65.3% (range 0 – 100%, IQR 53.6% - 83.9%) and the median percentage of cows 
aged >2 years on milk negative farms was 62.5% (range 0 – 100%, IQR 53.3% - 71.7%). 
The univariate analyses after adjusting for sampling variables (dairy cooperative and farm size) 
showed that years of farm business, cow breed, breeding methods, cow bedding type, frequency of floor 
cleaning, having separate birthing stables and separate stables for quarantine, newly purchased animals 
in the past 6 months, having more than 80% of cows ≥ 2 years of age, the quarantine of newly purchased 
animals, practices of cleaning after birth, and distances from the nearest milk positive farms were 
important factors (Table 6). These variables were determined for collinearity. The results showed that 
ever quarantining newly purchased animals and having separate stables for quarantine; ever cleaning the 
cow birthing area right after calving and having separate birthing stables; and farm size and number of 
cows age 2 years or older were highly correlated. Thus, only the quarantine of newly purchased animals 
and cleaning of the birthing area right after birth were included in the multivariate analysis. The 
percentage of cows age ≥ 2 years was used in the model instead of the number of cows aged > 2 years 
to account for age.  
The multivariate logistic regression model showed that dairy cooperative, farm size, cow bedding 
type, distance from positive farms, cleaning after birth, and quarantining newly purchased animals were 
associated with the odds of having antibodies in BTM with each variable adjusted for all others (Table 2). 
Cleaning the cow birthing area right after birth (OR 0.27, 95%CI 0.08 - 0.87) and quarantining newly 
purchased animals (OR 0.52, 95%CI 0.29 - 0.93) were negatively associated with the presence of 
antibodies to C. burnetii in BTM. In addition, farms with >40 cows and a farm located within 1 kilometer of 
a milk positive farm were positively associated with the antibodies to C. burnetii in BTM.  
Different types of stall surfaces seemed to be an important factor in our analysis. Farms with a 
concrete and rubber mat base (OR 3.90, 95%CI 1.34 – 11.39) and concrete base (OR 2.07, 95%CI 0.97 
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– 4.43) were positively associated with the odds of antibodies in BTM compared to concrete and soil 
base. Although the percentage of cows aged ≥ 2 years within the farm as a continuous variable was not 
statistically significant, further exploratory analysis found that having more than 80% of cows aged ≥ 2 
years of age was positively associated with the odds of positive milk (OR 2.3, 95%CI  1.09 - 5.06) (Table 
3). In addition, having newly purchased cows in the past 6 months was negatively associated with the 
odds of antibodies to C. burnetii in BTM (OR 0.48, 95%CI 0.24 – 0.97) (Table 8). 
A separate analysis comparing farms with positive and negative BTM was performed. There were a 
totally of 249 farms composed of 115 positive farms and 134 negative farms included in the analysis. The 
multivariate analysis (Supplemental Table 2) showed similar results compared to the analysis of positive 
vs. non-positive farms. Cooperative, farm size, ever quarantining of a newly purchased animal in the past 
6 months, and proximity to positive farms were significantly associated with seropositivity in BTM. 
Although having more than 80% of cows aged ≥ 2 years of age, ever cleaning the birthing area right after 
birth, and stall base were not statistically significantly associated with the prevalence of antibodies to C. 
burnetii in BTM, the odds ratio showed a pattern similar to the analysis of positive vs non-positive farms. 
Positive farms were clustered in particular areas (Figure 7). Spatial analysis showed the evidence for 
spatial autocorrelation for BTM positive and negative farms using Morans I statistic (z-score was 2.35 and 
p-value 0.02).  
  
Figure 7. Distribution of dairy farms by Bulk Tank Milk (BTM) results 
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Farm investigation 
Ninety-nine out of 115 milk positive farms were visited (86.08%).  Of the 16 missing farms, 12 farms 
could not be visited because of a disease outbreak in the cows, 3 farms stopped their business, and 1 
farm was unwilling to participate. Vaginal swabs and sera from 790 cows, 99 swab samples from birthing 
areas, 99 samples of soil at the end of the water drainage, leftover food samples in trays from 57 farms, 
ticks from 53 farms, and 39 whole blood samples of other animals in the farms were collected during 
these farm visits. Samples from other animals included 30 dogs, 4 cats, 4 chickens, and 1 horse.  
Figure 8 showed examples of farm environment.  
The overall unweighted seroprevalence to C. burnetii infection in cow was 28.35% (224/790) and the 
unweighted prevalence of C.burnetii DNA in vaginal swab samples was 18.48% (146/790). At the herd 
level, 91.9% (91/99) of the farms with positive BTM had at least one seropositive cow and 39.4% (39/99) 
of the farms had at least one cow with evidence of C. burnetii DNA using PCR. The median within-herd 
seroprevalence was 25.0% (range 0 – 62.50%, IQR 12.50% – 37.50%) and the median within-herd 
prevalence of C. burnetii DNA in vaginal swabs was 0 (range 0 – 100%, IQR 18.40% - 31.60%). In 
addition, 12.12% (12/99) of the environmental swabs from the cow birthing area, 7.07% (7/99) of the soil 
samples, and 1.92% (1/52) of ticks from 52 farms were PCR positive. None of the other animals sampled 
had evidence of C. burnetii DNA in their blood.  
 
Figure 8. Examples of farm environment 
 
Table 6. Results of univariate analyses of factors associated with dairy farms with milk positive,  
Chiang Mai, Thailand 2015 
 
 Positive vs non-positive (N=282) 
Covariates OR* 95% CI p-value 
Cooperatives    0.0003 
Farm size    0.0376 
Years of farm business 1.021 0.993 1.049 0.1476 
Breed (Holstein vs. Holstein and others) 1.512 0.846 2.703 0.1631 
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Breeding: Artificial Insemination(AI) and natural mating vs. AI only 5.195 0.527 51.207 0.1582 
Number of cows age<1 1.03 0.969 1.094 0.3489 
Number of cows age 1- < 2years 1.017 0.98 1.056 0.3725 
Number of cows age ≥ 2 years 1.032 1.006 1.059 0.0147 
Percentage of cow age ≥ 2 years 1.868 0.385 9.06 0.4381 
Proportion of cow age ≥ 2 years on the farm    0.0384 
 - < 80%   Ref.  
 - ≥ 80% 2.142 1.041 4.406 0.0384 
Barn type (free vs. tie-stall barn) 1.173 0.67 2.054 0.5761 
Airflow in the stable (natural airflow vs. natural and fan) 1.289 0.351 4.735 0.7027 
Stall bases: (Cow bedding type)    0.0266 
 - Concrete and ground vs. concrete only 0.494 0.237 1.03 0.0598 
 - Concrete and rubber mats vs. concrete only 1.945 0.873 4.332 0.1035 
Frequency of floor cleaning    0.223 
 - 1 time/day vs. > 2times/day 2.557 0.384 17.011 0.2266 
 - 2 times/day vs. >2 times/day 0.687 0.35 1.349 0.0946 
Frequency of antiseptic used    0.46 
 - Never vs. always 1.739 0.675 4.477 0.2137 
 - Sometime vs. always 1.059 0.56 2.002 0.4454 
Having separate birthing stable (Yes vs. No) 0.607 0.301 1.222 0.1622 
Having birth at the tiding area (Yes vs. No) 1.346 0.795 2.279 0.2686 
Cleaning the birthing area right after birth    0.0494 
 - Sometimes vs. no 0.278 0.059 1.321 0.1076 
 - Always vs. no 0.245 0.08 0.754 0.0142 
Newly purchased animal in the past 6 months (Yes vs. No) 0.526 0.277 0.996 0.0487 
Ever quarantine newly purchased animals 0.566 0.331 0.971 0.0386 
Having separate stables for quarantine (Yes or No) 0.46 0.235 0.9 0.0234 
Raising other animals on the farm (Yes or No) 1.307 0.78 2.19 0.3098 
Raising dog  on the farms    0.4289 
 - No dog but others vs. no animal 1.045 0.493 2.216 0.6953 
 - Dog or dog with others vs. no animal 1.457 0.816 2.6 0.2405 
Raising cat on the farms    0.3829 
 - No cat but others vs. no animal 1.48 0.84 2.605 0.8468 
 - Cat or cat with others other vs. no animal 0.938 0.418 2.108 0.25 
Rat on a farm (Yes or No) 1.352 0.76 2.403 0.3044 
Tick control (Yes or No) 1.033 0.529 2.017 0.9238 
History of abortion in other animals (Yes or No) 6.362 0.317 127.64 0.2265 
Distance from the positive farms    0.0096 
 - > 1 to 2 kilometers vs. > 2 kilometers 1.55 0.534 4.499 0.4202 
 - ≤ 1 kilometer vs. > 2 kilometers 3.164 1.365 7.337 0.0073 
*Adjusted for all exposure factors, OR: Odds ratio, 95%CI: 95% confidence interval 
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Table 7. Results of multivariate analysis of factors associated with dairy farms with seropositive vs. farms 
with non-positive milk, Chiang Mai, Thailand 2015 
 
Covariates OR 
95%Confidence 
Limits 
chi2 p-
value 
type3 p-
value 
Dairy cooperative         0.0315 
 - Coop5       Ref   
 - Coop1 2.419 0.87 6.729 0.0905   
 - Coop2 1.558 0.569 4.262 0.388   
 - Coop3  1.309 0.441 3.883 0.6277   
 - Coop4 0.545 0.162 1.832 0.3263   
Farm size         0.0117 
 - Farm with 1 - 20 cows       Ref   
 - Farms with 21 - 40 cows 1.47 0.604 3.577 0.3957   
 - Farms with > 40 cows 3.004 1.281 7.044 0.0114   
Stall base         0.0401 
 - Concrete and ground       Ref   
 - Concrete  2.068 0.965 4.433 0.0619   
 - Concrete and rubber mat 3.901 1.337 11.39 0.0127   
Ever clean cow birthing areas         0.028 
 - No       Ref   
 - Yes 0.267 0.082 0.867 0.028   
Ever quarantine newly purchased animals         0.0265 
 - No       Ref   
 - Yes 0.522 0.293 0.927 0.0265   
Distance from positive farm         0.015 
 - > 2 kms       Ref   
 - ≤ 1 km 2.941 1.22 7.088 0.0163   
 - > 1 to ≤ 2 kms 1.302 0.42 4.042 0.6475   
Proportion of cows aged > 2 years on farm 2.125 0.404 11.19 0.3739 0.3739 
Ref: reference 
 
  
62 
Table 8. Results of multivariate analysis of factors associated with dairy farms with seropositive vs farms 
with non-positive milk (Explore effect of percentage of cow aged > 2 year as a categorical variable), 
Chiang Mai, Thailand 2015 
 
Covariates OR 
95%Confidence 
Limits 
chi2 p-
value 
type3 p-
value 
Dairy cooperative         0.0301 
 - Coop5       Ref   
 - Coop1 2.399 0.849 6.781 0.0989   
 - Coop2 1.328 0.475 3.709 0.5886   
 - Coop3  1.239 0.414 3.706 0.7014   
 - Coop4 0.517 0.151 1.772 0.2939   
Farm size         0.0085 
 - Farm with 1 - 20 cows       Ref   
 - Farms with 21 - 40 cows 1.528 0.614 3.803 0.3626   
 - Farms with > 40 cows 3.24 1.342 7.825 0.009   
Stall base         0.043 
 - Concrete and ground       Ref   
 - Concrete  2.093 0.959 4.566 0.0635   
 - Concrete and rubber mat 3.928 1.324 11.649 0.0137   
Ever clean cow birthing areas          0.0263 
 - No       Ref    
 - Yes 0.268 0.084 0.856 0.0263 
 
Ever quarantine newly purchased animals           
 - No       Ref   
 - Yes 0.541 0.301 0.974 0.0406 0.0406 
Distance from positive farm         0.0162 
 - > 2 kms       Ref   
 - ≤ 1 km 2.878 1.174 7.056 0.0209   
 - > 1 to ≤ 2 kms 1.228 0.39 3.862 0.7253   
Proportion of cows aged > 2 years on farm          0.0302 
 - < 80%       Ref   
 - ≥ 80% 2.344 1.085 5.061 0.0302 
 
Newly purchased cows in the past 6 months           0.04 
 - No       Ref   
 - Yes 0.477 0.235 0.967 0.04 
 
Ref: reference 
 
Discussion 
This study measured the prevalence of C. burnetii antibody in BTM from five dairy cooperatives in 
Chiang Mai Province, Thailand.   Antibodies to C. burnetii were present in 39.8% (95% CI 32.74% - 
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44.83%) of farms. The presence of C .burnetii antibodies in milk varied by dairy cooperative, and 
geographic area where the farms were located. The study shows that the number of cows, the proximity 
to other milk positive farms, different types of stall bases, cleaning right after cow births, and quarantine 
practices were associated with the prevalence of C. burnetii antibodies in milk. As expected, 92% of 
farms with antibodies in BTM contained at least one seropositive cow.  Seroprevalence of C. burnetii 
infection was 28% at the individual cow level and the median within-herd seroprevalence was 25% (range 
0 – 62.5%, IQR 12.5% – 37.5%).  These data imply that an antibody in BTM is a good marker of  
C. burnetii-infected herds.  
The screening of bulk tank milk by ELISA has been done elsewhere (77, 127), but had not previously 
been done in Thailand. The prevalence of antibody for C. burnetii in dairy cattle BTM in our study was 
lower compared to studies in the Netherlands (81.6%) (127), Spain (66.9%) (128), Ireland (64.5%) (77), 
and Iran (45.4%) (129). However, comparing seroprevalence between studies was challenging because 
each study used different tests and different cut-off values. A review by Guatteo et.al. showed that Q 
fever has been reported from all five continents and the prevalence of C. burnetii infection, regardless of 
laboratory methods and cut-off values, varied from 4.4% - 100% at the herd level (66). Similar to other 
studies (77, 125, 127), we found that farms with more cows were more likely to have C. burnetii 
antibodies in milk. Farms with larger numbers of cows might have more susceptible hosts so that infection 
can circulate within the farms without detection. A previous study showed that age is an important factor 
associated with seropositivity: the presence of older cows was associated with increased seropositivity 
(77). Our study showed that farms with the percentages of cows aged ≥ 2 years greater than 80% of the 
total cow population was significantly more likely to have antibodies to C. burnetii in BTM. Older cows with 
persistent exposure and partial immunity to bacteria might serve as a reservoir.  
Previous studies showed that C. burnetii is extensively shed during calving and can persist in the 
environment for years afterwards (107). In infected farms, 12% of swabs from cow birthing areas and 7% 
of soil at the end of the farm drainage were tested positive for C. burnetii DNA. Furthermore, our study 
showed that cleaning the birthing areas after calving was negatively associated with the presence of the 
antibody in milk. These findings emphasize the importance of environmental decontamination especially 
after calving to prevent the spread of infection within herds as well as to other animals and humans. 
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Quarantining newly purchased animals was negatively associated with the presence of antibodies to 
C. burnetii in milk. Quarantining newly purchased animals is recommended for all farms for biosecurity 
purposes. Nevertheless, for Q fever, quarantine alone might not be sufficient since C. burnetii infected 
animals are mostly asymptomatic (6). More importantly, C. burnetii transmission is mainly airborne and 
windborne; thus, it does not require close contact to spread. The apparent protective effect of quarantine 
in our study might reflect that it is practiced more often on farms with more concerns for biosecurity. 
Newly purchasing cows over the past 6 months was inversely associated with the odds of having an 
antibody in BTM in our study. This finding can be explained because infection can persist on farms and 
newly purchased animals could be less likely to be exposed to the pathogen.  
Stall bases were found to be significant factors in our study. Having concrete or concrete with rubber 
mats as the stall base were positively associated with positive BTM. Rubber mats were designed to 
provide cushions for the cows. However, rubber mats could be a sustainable source of bacteria if 
cleaning and disinfection is not properly performed. These mats require maintenance and replacement. 
We observed that some of the farms used old rubber mats without replacements.  
Living close to farms that had a history of abortion due to C. burnetii infection in ruminants was 
associated with an increased C. burnetii seroprevalence in humans (130). A study in the Netherlands 
showed that living within 2 kilometers of positive farms was associated with seropositivity in humans. Our 
study showed that proximity to BTM positive farms, especially within 1 kilometer, was positively 
associated with the prevalence of C. burnetii antibodies at the herd level. In Chiang Mai dairy cattle farms 
were clustered in particular areas, especially in areas where farms from coop1, coop2, and coop3 were 
located. This could explain the differences of prevalence in BTM by dairy cooperatives.  
Our results presented in this paper have some limitations since they are from a cross-sectional 
analysis of baseline data; hence, the temporal sequences of exposure and outcome are uncertain. This 
study was conducted in only one province, Chiang Mai, and generalizability could be limited. 
Nonetheless, the findings from this study enhance the knowledge of C. burnetii infection and its risk 
factors on dairy cattle farms in Thailand. Farm visits and sample collection from individual cows were only 
performed on the farms with positive milk. Thus, information at the cow level was limited to positive farms 
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and cannot be generalized to the farms with negative BTM. Other studies focusing on individual cows 
would improve the knowledge of the roles of C. burnetii infection in dairy cattle in Thailand. 
This study was among the first to evaluate the prevalence of antibodies to C. burnetii in BTM in 
Thailand. The overall prevalence was approximately 39%. Among BTM positive farms, seroprevalence of 
C. burnetii infection at the herd level was 91.2%, suggesting that milk would be a favorable choice for 
screening for C. burnetii infection at the herd level. Contrarily, a greater proportion of older cows and 
proximity to other milk positive farms were positively associated with the presence of C. burnetii infection 
in milk. Farm practices such as cleaning cow birthing areas after birth and quarantining newly purchased 
animals were associated with protection against antibodies in BTM.   
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Supplemental Table1. Farm characteristics and seroprevalence of C. burnetii in BTM on farms 
participating in the study, Chiang Mai, Thailand 2015 
 
Characteristics N* Prevalence 95%LCI 95%UCI 
Overall seroprevalene of C. burnetii in milk 282 38.98% 32.91% 45.05% 
Cooperatives         
 - Coop1 78 55.16% 42.99% 67.34% 
 - Coop2 73 37.36% 25.53% 49.18% 
 - Coop3 52 36.51% 21.94% 51.08% 
 - Coop4 40 25.69% 7.91% 43.47% 
 - Coop5 39 22.48% 7.64% 37.32% 
Farm size         
 - 1 - 20 cows 40 31.62% 16.28% 46.96% 
 - 21 - 40 cows 95 36.67% 26.53% 46.82% 
 - > 40 cows 147 47.18% 38.96% 55.40% 
Breeds         
 Holstein         
 - Holstein only 203 39.74% 32.39% 47.09% 
 - Holstein and other breeds 79 36.05% 24.05% 48.05% 
 Reddane         
 - No Reddane on the farm 251 39.23% 32.63% 45.83% 
 - Had Reddane on the farm 31 35.11% 15.03% 55.19% 
 Jersey         
 - No Jersey on the farm 269 38.57% 32.19% 44.95% 
 - Had Jersey on the farm 13 44.01% 11.30% 76.73% 
 Sahiwal         
 - No Sahiwal on the farm 267 39.60% 33.17% 46.03% 
 - Had Sahiwal on the farm 15 23.29% -3.57% 50.15% 
 Brown Swiss         
 - No Brown Swiss on the farm 264 38.51% 32.09% 44.93% 
 - Had Brown Swiss on the farm 18 44.47% 17.41% 71.53% 
 Beef cattle         
 - No Beef cattle on the farm 263 38.99% 32.54% 45.44% 
 - Had Beef cattle on the farm 16 27.59% 0.03% 55.14% 
Feeding system          
 - Eat inside the barn 264 38.80% 32.36% 45.25% 
 - Eat inside the barn and free grazing on the farm 18 38.52% 11.82% 65.21% 
Barn         
  - Free-stall barn 123 30.96% 22.02% 39.89% 
  - Tie-stall barn 158 43.89% 35.42% 52.35% 
Breeding methods         
  - Artificial insemination 277 38.33% 32.06% 44.60% 
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  - Mixed (natural & artificial insemination) 5 79.04% 21.51% 136.57% 
Number of cows by age         
No of cows age less than 1         
  - 0 cows 6 75.73% 29.84% 121.63% 
  - 1 - 20 cows 272 37.65% 31.37% 43.92% 
  - > 20 cows (range 21 - 30) 2 46.97% -586.01% 679.94% 
No of cows age 1 to less than 2 years         
  - 0 cows 18 36.94% 10.89% 63.00% 
  - 1 - 20 cows 236 37.96% 31.19% 44.74% 
  - > 20 cows (range 21 - 35) 25 53.15% 30.37% 75.93% 
Number of cows age 2 or older         
  - 1 - 20 cows 111 31.52% 22.35% 40.68% 
  - 21 - 40 cows 127 42.94% 33.49% 52.40% 
  - >40 cows (range 41 - 81) 40 63.54% 47.94% 79.15% 
Air flow system         
 - Natural airflow  271 38.67% 32.32% 45.02% 
 - Natural airflow and fan 11 43.00% 7.98% 78.03% 
Stall bases         
  - Concrete only 198 40.68% 33.14% 48.23% 
  - Concrete and earth floor 52 19.57% 8.73% 30.40% 
  - Concrete and rubber mats 32 58.95% 39.80% 78.11% 
Separate birthing stable         
  - No 232 41.03% 34.09% 47.98% 
  - Yes 50 26.62% 13.45% 39.79% 
Raising other animals on farm         
  - No 155 35.03% 26.91% 43.16% 
  - Yes 127 43.59% 33.93% 53.24% 
Dogs         
  - No, but raising other animals 155 35.03% 26.91% 43.16% 
  - Yes, dog only 41 37.04% 19.98% 54.09% 
  - Yes, dog with other animals 86 47.09% 35.22% 58.96% 
Cats         
  - No, but raising other animals 155 35.03% 26.91% 43.16% 
  - Yes, cat only 93 45.23% 33.81% 56.66% 
  - Yes, cat with other animals 34 38.61% 19.90% 57.32% 
Abortion of other animals on farm         
  - No 123 42.99% 33.19% 52.80% 
  - Yes 4 70.00% -19.14% 159.14% 
Rats         
  - No 78 38.05% 26.01% 50.09% 
  - Yes 204 39.10% 31.76% 46.43% 
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Wild animals         
  - No 267 38.55% 32.17% 44.93% 
  - Yes 15 43.88% 11.48% 76.28% 
Farm management/cleaning         
Cleaning the floor         
  - 1 time/day 6 69.43% 15.39% 123.48% 
  - 2 times/day 224 37.26% 30.24% 44.28% 
  - >2 times/day 52 41.52% 26.98% 56.06% 
Liquid used for cleaning floor         
  - Water  261 39.38% 32.88% 45.88% 
  - Water with chlorine 20 32.40% 8.50% 56.30% 
Frequency of antiseptic used for cleaning         
  - Never 32 45.48% 24.91% 66.04% 
  - Ever 250 37.88% 31.33% 44.43% 
Waste (feces) management         
 Left in the environment         
  - No 276 39.20% 32.89% 45.51% 
  - Yes 6 13.08% -22.26% 48.41% 
 Fermenting         
  - No 233 37.70% 30.93% 44.47% 
  - Yes 49 44.68% 28.59% 60.78% 
 Dry and sell         
  - No 5 15.52% -30.48% 61.51% 
  - Yes 277 39.10% 32.81% 45.40% 
Birthing management         
  - Only helped sometimes 167 39.98% 31.81% 48.15% 
  - Always helped with birthing 115 37.16% 27.39% 46.93% 
Birth management         
 Having separate birthing stable         
  - No 232 41.03% 34.09% 47.98% 
  - Yes 50 26.62% 13.45% 39.79% 
Cleaning the stable right after birthing         
  - No 17 73.88% 49.83% 97.92% 
  - Sometime 14 37.94% 5.98% 69.90% 
  - Always   251 36.58% 30.08% 43.09% 
Newly purchased animals in the past 6 months         
  - No 218 42.65% 35.38% 49.93% 
  - Yes 64 26.62% 15.22% 38.02% 
Quarantine newly purchased animals          
 - Never 180 42.96% 35.01% 50.90% 
 - Ever 102 31.05% 21.16% 40.94% 
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Having separate stable for quarantine         
  - No 225 41.94% 34.84% 49.04% 
  - Yes 56 25.98% 13.61% 38.36% 
Tick control         
 Practice tick control         
  - No 52 35.52% 20.61% 50.42% 
  - Yes 230 39.56% 32.65% 46.47% 
Antibiotic use in the past 6 months         
  - No 72 42.28% 29.57% 54.99% 
  - Yes 208 37.08% 29.91% 44.25% 
Distance from milk positive farm         
  - ≤ 1 kilometer  190 47.35% 39.46% 55.25% 
 - > 1 to 2 kilometers 40 23.52% 9.62% 37.41% 
 - > 2 kilometers  49 17.48% 6.53% 28.43% 
*N: number of farms 
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Supplemental Table 2. Results of multivariate analysis of factors associated with dairy farms with milk 
seropositive (Comparing farms with positive vs farms with negative milk) (N=249), Chiang Mai, Thailand 
2015 
 
Covariates OR 
95%Confidence 
Limits 
chi2 p-
value 
type3 p-
value 
Dairy cooperative         0.0131 
 - Coop5        Ref.   
 - Coop1 2.554 0.893 7.306 0.0804   
 - Coop2 2.24 0.771 6.512 0.1384   
 - Coop3  1.394 0.455 4.27 0.5603   
 - Coop4 0.515 0.149 1.788 0.2964   
Farm size         0.0248 
 - Farm with 1 - 20 cows        Ref.   
 - Farms with 21 - 40 cows 2.162 0.816 5.731 0.121   
 - Farms with > 40 cows 3.46 1.375 8.706 0.0084   
Stall base (cow bedding type)         0.0834 
 - Concrete and ground        Ref.   
 - Concrete  1.491 0.643 3.458 0.3516   
 - Concrete and rubber mat 3.868 1.153 12.971 0.0284   
Ever clean cow birthing areas           
 - No        Ref.   
 - Yes 0.346 0.108 1.11 0.0744 0.0744 
Ever quarantine newly purchased animals           
 - No           
 - Yes 0.541 0.292 1.002 0.0507 0.0507 
Distance from positive farm          0.0064 
 - > 2 kms        Ref.   
 - ≤ 1 km 3.457 1.375 8.692 0.0084 
 
 - > 1 to ≤ 2 kms 1.338 0.412 4.343 0.6278   
Proportion of cows aged > 2 years on the 
farm 
          
 - < 80%        Ref.   
 - ≥ 80% 2.053 0.889 4.743 0.0921 0.0921 
Newly purchased cows in the past 6 months            
 - No        Ref.   
 - Yes 0.549 0.258 1.167 0.1188 0.1188 
*Ref: Reference 
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CHAPTER 6 
SEROPREVALENCE AND FACTORS ASSOCIATED WITH COXIELLA BURNETII INFECTION 
AMONG DAIRY FARMERS, CHIANG MAI, THAILAND 2015 
 
Introduction 
Q fever, a zoonotic disease, is caused by gram negative intracellular bacteria, Coxiella Burnetii. It 
was first identified in 1937 after an outbreak of an unknown febrile illness among abattoir workers in 
Australia (8). Domestic ruminants are the common reservoirs for Q fever infection in humans. Inhalation 
of contaminated dust or particles is the main route of transmission. Other routes of transmission such as 
food-borne, person-to-person transmission, or sexual transmission are rarely been reported (4). The 
majority of people infected with C. burnetii are asymptomatic. However, about 40% of infected humans 
develop acute Q fever which may present as acute febrile illness, pneumonia, or hepatitis. Approximately 
2–5% of the infected develop endocarditis with up to 20% of the infected developing chronic fatigue 
syndrome (4, 10).  
Similar to human infection, Q fever infection in animals is mostly asymptomatic. Some animals, 
particularly sheep and goats, develop reproductive problems such as abortions, infertility, and weak 
offspring. Infection in cows can cause metritis (6). Infected animals can shed bacteria regardless of 
clinical symptoms (107). C. burnetii is classified a category B  bioterrorism agent since the pathogen is 
highly contagious and can result in moderate morbidity rates, but low death rates (1). The largest 
outbreak of Q fever ever reported was in the Netherlands in 2007 where more than 4,000 cases and 
major economic loses were reported (119).  
Knowledge of the epidemiology of Q fever in Thailand is limited. Laboratory capacity for Q fever 
diagnosis was not available in Thailand before 2012. With support from the US.CDC, diagnostic 
capacities were strengthened after the first two reported cases of Q fever endocarditis in 2012 (13). To 
date, staffs from 5 institutes have been trained for Q fever diagnosis using Indirect Immunofluorescense 
Assay (IFA). Polymerase Chian Reaction (PCR) for Q fever diagnosis is available at the national level 
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(National Institute of Health (Thai-NIH) and National Institute of Animal Health (NIAH)) and at some 
veterinary research centers and university hospitals. Previous studies reported the seroprevalence of Q 
fever was approximately 1% among patients presenting with acute undifferentiated fever in the two 
tertiary care hospitals in Thailand (12, 14). A 2012 survey among occupationally exposed people and 
ruminants using Enzyme Linked Immunosorbent Assay (ELISA) in two provinces of Thailand showed that 
seroprevalence to C. burnetii among farmers was 43% (68/159) in Chiang Mai and 3% (15/502) in 
Nakornratchasima provinces (unpublished). Another study in Chiang Mai found the seroprevalence of Q 
fever among farmers and livestock officers was 16% using IFA (unpublished). Since information 
concerning the epidemiology of Q fever in Thailand is limited and Q fever can cause an outbreak, 
particularly among occupationally exposed people with subsequent chronic life threatening complications, 
the Bureau of Epidemiology in collaboration with Chiang Mai public health and animal health offices, the 
Thai-NIH, the NIAH, and the Thai-US. CDC Collaboration initiated a one-year prospective cohort study to 
understand the burden, risk factors, and clinical manifestation of Q fever among dairy cattle farms and 
farmers. This study was conducted from June 2015 to August 2016. We report here the preliminary 
analysis of baseline information of the seroprevalence and the factors associated with C. burnetii infection 
among farmers. 
 
Methods  
Study design and study population  
This study is the analysis of baseline data of a one-year prospective cohort study conducted among 
dairy farms and farmers of the five dairy cooperatives in Chiang Mai Province.  A description of the cohort 
was given elsewhere (Manuscript submitted). In summary, a cohort study was conducted from June 2015 
– August 2016, in areas where seroprevalence to Q fever was reported in animals and humans. The 
sample size for the project was based on the results from a previous study where the prevalence of Q 
fever among dairy farmers was 16% (unpublished data). The CSurvey program was used for sample size 
calculation (117). The estimated one-year incidence of seroconversion of C. burnetii infection among 
farmers was 1.6%. The half-length of the 95% confidence interval was specified as 1.6%, with a design 
effect of 2 for an average of 2 farmers per farm. Thus, the number of clusters needed for the study was 
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260 farms and 520 farmers. We assumed that the prevalence of C. burnetii infection among farmers at 
baseline was 16%. To account for the baseline prevalence, we needed to screen a total sample size of 
620 farmers from 310 farms at the beginning of the study (Manuscript submitted). 
Farms were randomly selected based on information provided by dairy cooperatives. However, no 
information about farmers was available in the dairy cooperative database. Short surveys to obtain the 
lists of farmer were conducted. The number of farmers from the selected farms varied from 1 to 8. To 
account for the variation of number of farmers to reach the targeted sample size, all farmers were 
selected at farms with 1 to 3 farmers and 3 farmers were randomly selected from farms with more than 3 
farmers by simple random sampling and random digit number. Eventually, 637 farmers were randomly 
selected. 
 
Data collection 
Selected farms and farmers were contacted by research assistants to make appointments for data 
collection date and time. Farmers were informed about the project and provided consent forms before 
data collection. Data were collected using face-to-face interviews by trained interviewers. Two types of 
questionnaires, one for individual farmers and another for farms, were used in the project. All enrolled 
farmers were interviewed using the farmer questionnaire and farm owners or farm representatives were 
interviewed about farm practices. Individual farmer’s demographic information, underlying illnesses, job 
descriptions, history of personal protective equipment used in the farm, and other exposure history to Q 
fever risk factors were collected in the farmer questionnaire. Information about farm characteristics, farm 
practices, and farm management were collected in the farm questionnaire.  
 
Laboratory analysis 
Blood samples were obtained on the day of the interview. Sera were extracted and frozen at – 20°C 
before transference to the Thai-NIH for IFA testing. IgG and IgM antibodies against C. burnetii phase I 
and phase II antigens were analyzed. IFA slides were coated with synthetic C. burnetii Nine Mile phase I 
and phase II antigens, provided by the Ricketsial Zoonoses Branch, CDC, Atlanta, USA. The IFA was 
performed following the US.CDC protocol (121). Sera were screened at the initial dilution of 1:16. An IFA 
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seropositive farmer was defined as one who had IgG antibody titer to C. burnetii either phase I or phase II 
antigen ≥ 1:64. All other titers were defined as seronegative. 
 
Data analysis 
Descriptive statistics including frequencies, mean, standard deviation, median, interquartile range, 
maximum and minimum of seropositive farmers, and covariates were calculated. Since farmers working 
at the same farms share certain common environments, a Generalized Estimating Equation (GEE) model 
was applied to deal with correlated data from within the farm. Each farm had its unique tank number 
which was used as a unique identifier in the analysis. The odds ratios (OR) and the 95% confidence 
intervals (CI) were estimated. Sampling variables including dairy cooperative and farm size were always 
included in the analysis. We performed univariate analyses to determine whether the covariates after 
adjusting for sampling variables were sufficiently important to be included in the multivariate model. Age 
was reported to be an important factor associated with seropositivity to C. burnetii in humans and was 
always included in the multivariate analysis. Variables with a p-value from type 3 GEE analysis ≤ 0.20 
were considered important and included in multivariate analysis. If the variables in univariate analyses 
were correlated, variables that were more informative were included in the multivariate analysis. 
Multivariate analyses were performed using manual forward elimination. Farm factors that were reported 
to be associated with the prevalence of antibody to C. burnetii infection in BTM, such as the practice of 
continually cleaning the birthing area immediately after birth, proximity to positive farms, and the presence 
of C. burnetii antibody in BTM were also examined in the multivariate analysis.  
Distribution of farmers on positive farms was presented on the map using ArcMap10.3.1 (ArcGIS 
10.3.1, Esri, Redlands, CA).  
 
Preliminary Results  
Among 637 randomly selected farmers, 532 farmers participated (83.5%) in the study. Among these 
532 farmers, 355 (67%) farmers did not have antibodies to C. burnetii at baseline, 90 (16.9%) farmers 
had IgG antibody against either C. burnetii phase I or phase II antigen ≥ 1:64, and 50 (9.4%) farmers had 
IgG antibody against either phase I or phase II antigen ≥ 1:128. In addition, two farmers who had IgG 
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antibody to phase II antigen ≥ 1:128 reported they had had a fever within the past 4 weeks.  One farmer 
had IgG antibody to C. burnetii phase I antigen 1:1024 suggestive of possible chronic Q fever infection, 
but she was asymptomatic.  
Seropositivity among farmers differed by dairy cooperative. The median age of farmers who were 
seropositive was higher than the seronegative farmers. In addition, the percent of seropositives was 
higher among those who assisted with calving and came into contact with cow birth product or placenta 
during calving. The proportion of seropositivity among farmers was higher among those who had never 
used gloves or masks when assisting with calving or coming into contact with cow birth products or 
placenta. Gender, dairy farm working experiences, and working hours per week were similar for both 
seropositive and seronegative farmers (Table 9). The prevalence of seropositive farmers was higher on 
farms with positive BTM. Moreover, the prevalence of seropositive farmers was higher on farms within a 2 
kilometer range of the positive farms (Table 9). Univariate analysis showed that age, having any 
underlying diseases, having ever assisted in cow birthing, having ever been in contact with cow birth 
products or placenta, having ever bathed a cow, having ever managed manure, and using gloves on the 
farms were significant (Table10). However, age, underlying diseases, assisting in calving and coming into 
contact with a cow’s birth products or placenta were related. Therefore, only age and coming into contact 
with a cow’s birth products or placenta were selected for multivariate analysis. 
 
Table 9. Characteristics of farmers participating in the study by the IFA results, Chiang Mai, Thailand 
2015 
 
Characteristics 
Number 
of farmer 
Seronegative 
(<1:64) 
Seropositive 
(≥1:64) 
Cooperatives       
 - Coop1 152 132(86.84%) 20(13.16%) 
 - Coop2 133 106(79.70%) 27(20.30%) 
 - Coop3 113 81(71.68%) 32(28.32%) 
 - Coop4 70 62(88.57%) 8(11.43%) 
 - Coop5 64 61(95.31%) 3(4.69%) 
Farm size       
 - 1 - 20 cows 70 59(84.29%) 11(15.71%) 
 - 21 - 40 cos 190 158(83.16%) 32(16.84%) 
 - > 40 cows 272 225(82.72%) 47(17.28%) 
Age (median, min, max) 532 49.67 (18.27,74.48) 51.91 (22.23,70.48) 
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Gender       
 -Female 207 175(84.54%) 32(15.46%) 
 -Male 325 267(82.15%) 58(17.85%) 
Underlying diseases       
 - No 415 348(83.86%) 67(16.14%) 
 - Yes 117 94(80.34%) 23(19.66%) 
Diabetes Mellitus (DM)       
 - No 517 431(83.37%) 86(16.63%) 
 - Yes 15 11(73.33%) 4(26.67%) 
 Hypertension       
 - No 486 402(82.72%) 84(17.28%) 
 - Yes 46 40(86.96%) 6(13.04%) 
Years of working experience 532  11 (0.25,40) 12 (1,39) 
Working hours/week 532  42 (0.66, 126) 42 (7,84) 
Live on farm       
 - No 289 244(84.43%) 45(15.57%) 
 - Yes 243 198(81.48%) 45(18.52%) 
Practices in the farm       
 Assist in birthing       
 - No 97 86(88.66%) 11(11.34%) 
 - Yes 435 356(81.84%) 79(18.16%) 
 Contact with birth products or placenta during 
birthing 
      
 - No 110 98(89.09%) 12(10.91%) 
 - Yes 422 344(81.52%) 78(18.48%) 
 Clean birth area       
 - No 103 89(86.41%) 14(13.59%) 
 - Yes 429 353(82.28%) 76(17.72%) 
 Milking       
 - No 109 88(80.73%) 21(19.27%) 
 - Yes 423 354(83.69%) 69(16.31%) 
 Bathing cows       
 - No 119 105(88.24%) 14(11.76%) 
 - Yes 413 337(81.6%) 76(18.4%) 
 Managing manure       
 - No 115 101(87.83%) 14(12.17%) 
 - Yes 417 341(81.77%) 76(18.23%) 
 Cleaning stables       
 - No 33 23(69.70%) 10(30.30%) 
 - Yes 499 419(83.97%) 80(16.03%) 
Personal Protective Equipment (PPE) use in farm activities 
Use of mask while assisting in cow birthing       
77 
 - Never 325 260(80.00%) 65(20.00%) 
 - Ever 110 96(87.27%) 14(12.73%) 
Use of gloves during assisting with cow birthing       
 - Never 304 241(79.28%) 63(20.72%) 
 - Ever 131 115(87.79%) 16(12.21%) 
Use of mask during exposure to cow birth 
products/placenta 
      
 - Never 311 249(80.06%) 62(19.94%) 
 - Ever 111 95(85.59%) 16(14.41%) 
Use of gloves during exposure to cow birth 
products/placenta 
      
 - Never 304 242(79.61%) 62(20.39%) 
 - Ever 118 102(86.44%) 16(13.56%) 
Use of mask during cleaning the birthing area       
 - Never 298 241(80.87%) 57(19.13%) 
 - Ever 131 112(85.5%) 19(14.5%) 
Use of gloves during cleaning the birthing area       
 - Never 310 248(80%) 62(20%) 
 - Ever 119 105(88.24%) 14(11.76%) 
Use of mask during milking       
 - Never 301 247(82.06%) 54(17.94%) 
 - Ever 122 107(87.7%) 15(12.3%) 
Use of gloves during milking       
 - Never 363 303(83.47%) 60(16.53%) 
 - Ever 60 51(85%) 9(15%) 
Use of mask when managing manure       
 - Never 270 212(78.52%) 58(21.48%) 
 - Ever 147 129(87.76%) 18(12.24%) 
Use of gloves when managing manure       
 - Never 317 251(79.18%) 66(20.82%) 
 - Ever 100 90(90%) 10(10%) 
Use of mask when cleaning stable       
 - Never 300 241(80.33%) 59(19.67%) 
 - Ever 147 128(87.07%) 19(12.93%) 
Using gloves  when cleaning stable       
 - Never 351 283(80.63%) 68(19.37%) 
 - Ever 96 86(89.58%) 10(10.42%) 
Use of mask when feeding cows       
 - Never 251 206(82.07%) 45(17.93%) 
 - Ever 163 136(83.44%) 27(16.56%) 
Use of mask when bathing cows       
 - Never 301 240(79.73%) 61(20.27%) 
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 - Ever 112 97(86.61%) 15(13.39%) 
Use of gloves when bathing cows       
 - Never 342 274(80.12%) 68(19.88%) 
 - Ever 71 63(88.73%) 8(11.27%) 
Personal Protective Equipment use in general        
 Mask       
 - Never 242 201(83.06%) 41(16.94%) 
 - Sometime 181 147(81.22%) 34(18.78%) 
 - Almost/always 109 94(86.24%) 15(13.76%) 
 Glove       
 - Never 300 243(81.00%) 57(19.00%) 
 - Sometime 162 136(83.95%) 26(16.05%) 
 - Almost/always 70 63(90.00%) 7(10.00%) 
 Wear boots       
 - Never 14 14(100%) 0(0%) 
 - Sometime 23 19(82.61%) 4(17.39%) 
 - Almost/always 495 409(82.63%) 86(17.37%) 
Raise other animals in the residential area       
 - No 91 77(84.62%) 14(15.38%) 
 - Yes 441 365(82.77%) 76(17.23%) 
Dogs       
 - No 75 65(86.67%) 10(13.33%) 
 - Yes 169 137(81.07%) 32(18.93%) 
Cats       
 - No 173 139(80.35%) 34(19.65%) 
 - Yes 71 63(88.73%) 8(11.27%) 
Water Buffaloes       
 - No 241 199(82.57%) 42(17.43%) 
 - Yes 3 3(100%) 0(0%) 
Pigs       
 - No 241 199(82.57%) 42(17.43%) 
 - Yes 3 3(100%) 0(0%) 
Chickens       
 - No 100 82(82%) 18(18%) 
 - Yes 144 120(83.33%) 24(16.67%) 
Ducks       
 - No 227 188(82.82%) 39(17.18%) 
 - Yes 17 14(82.35%) 3(17.65%) 
Other animals       
 - No 526 436(82.89%) 90(17.11%) 
 - Yes 6 6(100%) 0(0%) 
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Previous work       
Ever worked on animal farms       
 - No 340 285(83.82%) 55(16.18%) 
 - Yes 192 157(81.77%) 35(18.23%) 
Other possible risks       
Had rats in the house       
 - No 139 108(77.7%) 31(22.3%) 
 - Yes 393 334(84.99%) 59(15.01%) 
Traveled to other dairy cow farms       
 - No 230 183(79.57%) 47(20.43%) 
 - Yes 302 259(85.76%) 43(14.24%) 
Traveled to farms selling cow meat       
 - No 524 435(83.02%) 89(16.98%) 
 - Yes 8 7(87.5%) 1(12.5%) 
Traveled to zoo       
 - No 509 424(83.3%) 85(16.7%) 
 - Yes 23 18(78.26%) 5(21.74%) 
Traveled to a goat farm       
 - No 530 440(83.02%) 90(16.98%) 
 - Yes 2 2(100%) 0(0%) 
Helped in birthing other animals       
 - No 524 435(83.02%) 89(16.98%) 
 - Yes 8 7(87.5%) 1(12.5%) 
Contact with feces from other animals       
 - No 465 385(82.8%) 80(17.2%) 
 - Yes 67 57(85.07%) 10(14.93%) 
Tick bite       
 - No/Not sure 443 370(83.52%) 75(16.93%) 
 - Yes 87 72(82.76%) 15(17.24%) 
Drank raw milk       
 - No 517 428(82.79%) 89(17.21%) 
 - Yes 15 14(93.33%) 1(6.67%) 
Ate raw meat       
 - No 323 269(83.28%) 54(16.72%) 
 - Yes 209 173(82.78%) 36(17.22%) 
Ate raw pork       
 - No 304 253(83.22%) 51(16.78%) 
 - Yes 228 189(82.89%) 39(17.11%) 
Ate raw Chicken       
 - No 513 425(82.85%) 88(17.15%) 
 - Yes 19 17(89.47%) 2(10.53%) 
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Cooked raw placenta       
 - No 230 191(83.04%) 39(16.96%) 
 - Yes 302 251(83.11%) 51(16.89%) 
Received blood transfusion       
 - No 517 431(83.37%) 86(16.63%) 
 - Yes 15 11(73.33%) 4(26.67%) 
Working areas       
Distance from positive farms       
 < 1 km 365 298(81.64%) 67(18.36%) 
 1 - <2 kms 74 57(77.03%) 17(22.97%) 
>= 2 kms 89 83(93.26%) 6(6.74%) 
BTM results       
 - BTM non-positive 304 271(89.14%) 33(10.86%) 
 - BTM positive 224 167(74.55%) 57(25.45%) 
*No farmer raised sheep or goats in the residential area. 
Table10. Univariate analysis of factors associated with seropositivity among farmers, Chiang Mai, 
Thailand 2015 
 
 
GEE (cut-off 1:64) outcome = 90/randomly 
selected farmers N=532 
Variables OR 95%LCI 95%UCI 
p-
value 
type3 
p-
value 
Coops         0.0031 
Farm size         0.9599 
Age (year) 1.0242 1.0029 1.0459 0.0254 0.0212 
Gender (male vs. female) 1.262 0.8221 1.9373 0.2873 0.2796 
Underlying disease 1.507 0.9389 2.419 0.0894 0.1143 
Diabetic Mellitus (DM)         0.2298 
 - No underlying disease       Ref.   
 - DM  2.1433 0.8470 5.4234 0.1075   
 - No DM, but had other disease 1.4111 0.8430 2.3619 0.1901   
Working experience (month) 1.0078 0.9837 1.0325 0.5299 0.5258 
Working hours/week 1.0024 0.9914 1.0136 0.6651 0.6725 
Live on farm 1.2428 0.7419 2.0817 0.409 0.4005 
Farm practices           
Assist in birthing 1.4962 0.7950 2.8159 0.2117 0.1784 
Contact with cow birth products/placenta during birthing 1.9437 1.0153 3.7213 0.0449 0.0234 
Clean birthing areas after birth 1.2987 0.6671 2.5285 0.442 0.4247 
Milking 0.7722 0.4822 1.2365 0.2819 0.3024 
Bathe cows 1.5100 0.8399 2.7148 0.1685 0.1545 
Manage manure 1.6084 0.8268 3.1287 0.1615 0.1334 
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Clean stables 1.2177 0.5975 2.4817 0.5876 0.5753 
Ever worked on animal farms 1.3880 0.7612 2.5312 0.2848 0.3108 
Personal Protective Equipment use           
Use mask on the farms         0.7272 
 - Sometime vs. never 1.0451 0.6106 1.7888 0.8721   
 - Always vs. never 0.8111 0.4080 1.6125 0.5504   
Use gloves on the farms         0.0955 
 - Sometime vs. never 0.7129 0.4103 1.2384 0.2297   
 - Always vs. never 0.4338 0.1736 1.0839 0.0738   
Other factors           
Rats in the house 0.7043 0.4258 1.1650 0.1722 0.2080 
Ever traveled to other dairy cow farms 0.7089 0.4528 1.1100 0.1326 0.1410 
Ever traveled to farms selling meat 0.7653 0.0548 10.691 0.8424 0.8290 
Ever traveled to the zoo 1.1900 0.3599 3.9349 0.7756 0.7669 
Ever had contact with other animal feces 0.7399 0.3815 1.4353 0.3729 0.3542 
Ever had a tick bite 0.8241 0.4372 1.5535 0.5498 0.5202 
Ever drank raw milk 0.3211 0.0545 1.8925 0.2094 0.0855 
Ever ate raw meat 0.9564 0.5969 1.5324 0.8530 0.8529 
Ever ate raw pork 1.1915 0.7085 2.0039 0.5088 0.5042 
Ever cooked raw placenta 0.9372 0.5934 1.4802 0.7810 0.7811 
Ever received blood transfusion 1.6715 0.7042 3.9674 0.2441 0.3412 
Ever washed your hands after animal contact 0.9417 0.4823 1.8385 0.8602 0.8597 
Ever eaten in the farm areas 0.8485 0.3955 1.8202 0.6731 0.6611 
Farm factors           
Clean area immediately after birth           
 - Always vs. not always 0.4401 0.211 0.9178 0.0286 0.0709 
Stall base (cow bedding type)         0.3950 
 - Cement and ground vs. cement only 0.8399 0.3771 1.8709 0.6695   
 - Cement and rubber mat vs. cement only 1.6214 0.8001 3.2859 0.1799   
Had separate stables for quarantine (Yes or No) 1.4735 0.8028 2.7045 0.2110 0.2414 
Ever quarantined newly purchased animal (ever vs. 
never) 
0.7828 0.4471 1.3703 0.3913 0.3939 
Distance from positive farms         0.1085 
 - < 1 km vs. ≥ 2 kms 2.4995 0.8658 7.2159 0.0903   
 - 1 - < 2 kms vs. ≥ 2 kms 3.2692 1.0237 10.4400 0.0456   
Positive BTM (yes vs. no) 2.8880 1.5830 5.2691 0.0005 0.0009 
*Ref.: Reference 
Figure 9 shows the distribution of proportion of seropositive farmers by subdistrict and the BTM 
results by farm location. Some areas, particularly the areas of coops1, 2, and 3, had a higher proportion 
of seropositive farmers which corresponded with the BTM results.  
82 
 
Figure 9. Distribution of BTM results and the proportion of seropositive farmers, Chiang Mai, Thailand 
2015 
 
Discussion   
The overall seroprevalence of C. burnetii infection among farmers in our study was 16.9%. The 
prevalence was similar to the study in Chiang Mai in 2012 (16%) (unpublished). It is possible that the 
disease could be endemic in the study areas without detection. Prevalence differed by dairy cooperative. 
Factors that might be associated with seropositivity among farmers include age, history of coming into 
contact with cows’ birthing products or placenta during calving, assisting in calving, using gloves, and 
managing manure. Baseline seroprevalence among farmers was similar to the survey conducted in three 
districts of Chiang Mai in 2012 (unpublished). However, seroprevalence was lower compared to studies 
among farmers in dairy cattle farms in the Netherlands (72.1%) (125) and Mongolia (35.6%) (126). 
However, comparing seroprevalence among studies can be challenging, since different cutoff values and 
sampling methods were used. Seropositivity among Thai farmers was associated with BTM results, 
suggesting that BTM screening would be beneficial for targeting health education for Q fever prevention 
among farmers.  
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Future work 
The next step is to incorporate farm factors and perform multivariate analyses using GEE to 
determine factors associated with the seroprevalence of C. burnetii infection among farmers. In addition, 
sensitivity analysis using different IgG antibody cutoff values will be conducted.  
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CHAPTER 7 
SUMMARY 
Discussion  
The results of our study add useful information regarding C. burnetii infection (Q fever) among a high 
risk population in Thailand. This is the first longitudinal study to determine the epidemiology of Q fever 
among dairy cattle farms and farmers in Thailand. Therefore, several outcomes regarding C. burnetii 
infection can be determined, for example, the incidence of Q fever and risk factors, antibodies’ response 
to C. burnetii infection, and clinical manifestations of cases. In addition, this study is the first to determine 
the prevalence of C. burnetii antibody in BTM at the herd level in Thailand. The study benefited from more 
than 80% participation, in which 92% of the randomly selected farms (282/306) and 83% of the randomly 
selected farmers (532/637) participated. 
Analysis of baseline information showed that the unweighted prevalence of C. burnetii antibody in 
BTM was 40.8% (115/282). This is lower when compared to studies from the Netherlands – 78.6% (131) 
and Spain – 66.9% (128), but similar in range when compared to studies from Iran (45.4%) (129) and 
Ireland (37.9%) (132). The high prevalence of antibodies in BTM represents past exposure to C. burnetii, 
but it might not signify active infection or active shedding on the farm. Laboratory diagnosis is crucial for 
C. burnetii infection since most infections in cows are asymptomatic and shedding is possible regardless 
of clinical presentations. A previous study showed no relationship between C. burnetii shedding and 
seroconversion in animals (107). Nonetheless, the prevalence of antibodies to C.burnetii could indicate 
the existence of infection in the area.  
Analyses of BTM data showed that positive BTM differed by dairy cooperative and farm size. Farms 
with positive milk were clustered in specific areas. The odds of positive BTM on farms with > 40 cows was 
3 times the odds of positive BTM on the farms with 1–20 cows (OR 3.00, 95%CI 1.28–7.04). However, 
our study showed that, cleaning the birthing area after calving (OR 0.27, 95%CI 0.08 - 0.87) and 
quarantining of newly purchased animals (OR 0.52, 95%CI 0.29 - 0.93) were 
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protective factors.Having more than 80% of cows ≥ 2 years of age (OR 2.3, 95%CI  1.09 - 5.06) and 
having an infected farm within 1 kilometer (OR 2.94, 95%CI 1.22 – 7.09) were positively associated with 
the prevalence of C. burnetii antibodies in BTM. Our findings are similar to previous studies where 
increasing herd size, increasing cows’ ages, and proximity to positive farms were positively associated 
with the prevalence of C. burnetii (77, 130, 133).  
In addition, results from our study showed that the prevalence of positive BTM differed by stall base. 
Farms with concrete and rubber mat bases (3.90, 95%CI 1.34-11.39) or concrete bases only (2.07, 
95%CI 0.97-4.43) were positively associated with the odds of positive BTM compared to farms with 
concrete and earth bases. Rubber mats are put in place for the comfort of the cows. Most farms did not 
have separate birthing stables; hence, calving was done in the tiding area. Secretions from calving could 
remain on the mat or stall bases if cleaning was not appropriately done. C. burnetii has a small cell 
variant stage which can be resistant to harsh environments, such as disinfectants, desiccation, and UV 
light  (123). As a result, completely clearing C. burnetii from the environment can be challenging. 
However, cleaning and disinfection in the birthing area after calving is recommended to reduce the 
sustainability of the bacteria in the environment (134).  
Of the 115 BTM positive farms, 99 were visited (86.1%). Results from farm investigations showed that 
91.9% (91/99) of the farms with positive milk had at least one cow seropositive to C. burnetii. This 
information suggests that BTM screening with ELISA could be a good marker for C. burnetii infection at 
the herd level. Furthermore, the environmental investigations during farm visits showed that C. burnetii 
DNA was identified from swabs of the birthing area (12.1%, 12/99), soil recovered at the edge of the 
water drainage system (7.1%, 7/99), and ticks (1.9%, 1/52). Ticks are suspected as a sustainable 
reservoir for C. burnetii in the environment as they can shed bacteria through their feces (20). Findings 
from environmental investigations in this study support evidence from BTM analysis and underscore the 
importance of C. burnetii contamination in the farm environment, which then influences the prevalence of 
C. burnetii infection in both animals and humans. Therefore, appropriate cleaning, disinfection, 
particularly during calving, and tick controls on farms are essential to C. burnetii control and prevention. 
For the farmers’ study, 532 of 637 randomly selected farmers participated (response rate 83.5%). 
Preliminary analysis shows that C. burnetii seroprevalence among the farmers was approximately 17%, 
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similar to the previous survey conducted in Chiang Mai in 2012 (16%) (unpublished data). 
Seroprevalence was lower compared to studies among veterinary students or farmers in Japan (35.6%) 
(70), Taiwan (26.3%) (135), Mongolia (35.6%) (126), and the Netherlands (72.1%) (125). However, 
different cutoff values were used which make comparison between studies difficult. Our preliminary 
analysis shows that seropositive farmers were likely to become exposed to the pathogen by direct contact 
with a cow’s birth products (OR 1.9, 95%CI 1.0 - 3.7). Furthermore, other farm factors such as proximity 
to positive farms and BTM results might influence seropositivity among farmers. A positive BTM was 
positively associated with the odds of seropositivity among farmers in the univariate analysis (OR 2.9, 
95%CI 1.6 - 5.3). Further multivariate analyses will be done to confirm this hypothesis.  
Measurement errors could be possible since we measured antibody response to C. burnetii infection 
in milk and farmers. Antibody levels depend on several factors, such as the immune response of each 
individual, laboratory methods, and experiences of the laboratory staff. To control for these errors, we 
used the same laboratory methods and the same readers throughout the study. In addition, sensitivity 
analysis using a different cutoff value was performed to determine possible risk factors. 
Before this study was launched, Q fever was unknown to farmers and rarely known to public health 
and animal health officers. Our baseline analysis shows that C. burnetii infection is prevalent in the study 
areas. The findings from our study provide evidence for Q fever prevention and control. Similar to another 
study (136), the results from our study suggests that BTM screening is a good indicator for C. burnetii 
infection at the herd level. Screening of BTM periodically can be an important tool to determine the 
prevalence of C. burnetii infection at the herd level. Therefore, health education for Q fever prevention 
can be targeted. Health care professionals and public health and animal health officers should be 
informed about Q fever in their areas. In addition, health education regarding Q fever prevention and 
biosecurity concerns on the farms need to be strengthened among livestock farmers in general.  
Vaccines are available for both humans and animals and are used in some countries, such as 
Australia (137). The most recent vaccine for humans can cause severe adverse reactions if it is given to 
an individual who has previously been infected. Therefore, prescreening, either by skin test or serological 
test, is required (25). In cattle, the review showed that vaccination before pregnancy resulted in the 
reduction of a significant amount of bacteria shedding when compared to vaccination during pregnancy 
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and a placebo (95). This study highlights the extent of Q fever in dairy cattle farms and farmers; however, 
the information from this study alone cannot provide evidence to support the importance of Q fever 
vaccination in general. Since vaccines are costly and vaccine administration is not feasible when 
laboratory facilities are limited, further information such as the prevalence of chronic Q fever endocarditis, 
the prevalence of Q fever in other ruminants, and vaccine cost effectiveness are needed in order to 
ascertain if vaccination is beneficial.  
 
Public health impact  
Since information on the epidemiology of Q fever in Thailand is limited, our study provides crucial 
information about the prevalence of C. burnetii infection among dairy cow farms and farmers. Considering 
its longitudinal design, we are able to evaluate the incidence and risk factors associated with C. burnetii 
infection and clinical presentations of Q fever patients. Therefore, the outcomes of this study provide 
scientific evidence for Q fever prevention and control in dairy cow farms and farmers in Thailand. Our 
analyses of baseline information among this high risk population underline the existence of C. burnetii in 
the study areas and factors associated with the prevalence of C. burnetii antibodies in BTM and farmers. 
Farmers and veterinary officers who work closely with ruminants are at risk of contracting C. burnetii 
infections. The results of this study will be presented to policy makers in the animal and public health 
sectors, hence appropriate prevention and control messages can be distributed to high risk populations in 
high risk areas. In addition, these results can be presented to the Thai Infectious Disease Medicine 
Council to improve physicians’ awareness of Q fever. Furthermore, this study highlighted the One-Health 
concept in which animal and public health sectors in Thailand collaborate to conduct a field investigation 
and laboratory testing of Q fever. 
 
Future work  
Further analyses of individual cow data from the farm investigation will be performed to understand 
the clinical presentation and the factors associated with the prevalence of seropositive cows and C. 
burnetii shedding. In addition, further analyses will be performed to understand the potential risk factors 
associated with the prevalence of seropositivity among farmers. Sensitivity analyses using different IFA 
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cutoff values will be applied in multivariate analysis using GEE to determine factors associated with 
seroprevalence of C. burnetii.  
Data collection and laboratory tests were still in process when the dissertation was written. Further 
analyses for the whole project will be performed when data collection and laboratory tests are completed. 
Analyses will be performed to determine the incidence of Q fever and risk factors associated with the 
disease. If there is evidence of acute or chronic Q fever infection, clinical presentations of Q fever cases 
will be described and factors associated with clinical presentation will be explored. In addition, analyses of 
BTM screening for all three time points will be done to determine factors associated with persistently 
positive or newly positive BTM. Information for all cows and environmental samples during the farm 
investigations will be determined to understand factors associated with seropositivity and shedding in 
cows and the roles of environmental contamination.  
Our study used ELISA screening of BTM as a proxy for C. burnetii infection at the herd level. 
Nonetheless, the presence of antibodies suggests previous exposure to C. burnetii and may not 
represent the evidence of shedding of bacteria. A previous study showed that seropositive animals might 
not shed the bacteria (50). Further laboratory study and analyses to understand the correlation between 
the antibodies to C. burnetii and the presence of C. burnetii DNA in BTM will be performed.  
Previous studies showed that C. burnetii infection related to dairy cows had a milder clinical 
presentation compared to sheep or goats (125, 138). Other research involving molecular epidemiology to 
identify C. burnetii genotypes should be done to understand the roles of C. burnetii genotypes and their 
clinical manifestation in both cows and humans.  In addition, the study of Q fever among other ruminants 
and other groups of occupationally exposed people will enhance our knowledge of the extent of Q fever in 
Thailand. 
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